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ABSTRACT 
 
Wnt/beta-catenin (βcat) signaling is critical for adrenal homeostasis. To elucidate how 
Wnt/βcat signaling elicits homeostatic maintenance of the adrenal cortex, we characterized the 
identity of the adrenocortical Wnt-responsive population. We find that Wnt-responsive cells 
consist of both Sonic Hedgehog-producing (Shh) adrenocortical progenitors and differentiated, 
steroidogenic cells of the zona glomerulosa, but not the zona fasciculata. Additionally, Wnt-
responsive cells are rarely actively proliferating.  To determine potential direct inhibitory effects 
of βcat signaling on zona fasciculata-associated steroidogenesis, we utilized the mouse ATCL7 
adrenocortical cell line that serves as a model system of glucocorticoid-producing fasciculata 
cells. Stimulation of βcat signaling caused decreased corticosterone release consistent with the 
observed reduced transcription of steroidogenic genes Cyp11a1, Cyp11b1, Star and Mc2r. 
Decreased steroidogenic gene expression was correlated with diminished Steroidogenic factor 1 
(Nr5a1, Sf1) expression and decreased occupancy on steroidogenic promoters. Additionally, βcat 
signaling suppressed the ability of Sf1 to transactivate steroidogenic promoters independent of 
changes in Sf1 expression level. To investigate Sf1-independent effects of βcat on 
steroidogenesis, we utilized Affymetrix gene expression profiling of Wnt-responsive cells in vivo 
and in vitro. One candidate gene identified, Ccdc80, encodes a secreted protein with unknown 
signaling mechanisms. We report that Ccdc80 is a novel βcat-regulated gene in adrenocortical 
cells. Treatment of adrenocortical cells with media containing secreted Ccdc80 partially 
phenocopies βcat-induced suppression of steroidogenesis, through an Sf1-independent 
  vii 
mechanism. The data presented in this thesis reveal multiple mechanisms of βcat-mediated 
suppression of steroidogenesis and suggests that Wnt/βcat signaling regulates adrenal 
homeostasis by inhibiting fasciculata differentiation in addition to promoting the undifferentiated 
state of progenitor cells. 
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CHAPTER I: INTRODUCTION 
 
The adrenal cortex is an exceptionally dynamic endocrine organ that is homeostatically 
maintained throughout life. This chapter presents the current knowledge of how adrenal 
development and postnatal maintenance is regulated by a large array of signaling molecules, 
including combinatorial inputs from distinct paracrine signaling pathways and the endocrine 
system.  
 
I. Adrenal Anatomy & Function 
The adrenal gland is composed of two discrete endocrine organs with distinct 
embryological origins. The outer adrenal cortex, derived from the intermediate mesoderm, is the 
primary site of corticosteroid biosynthesis. The inner adrenal medulla, formed from the neural 
crest, produces catecholamines that serve as mediators of the ‘fight-or-flight” response. The 
organization of the adrenal cortex was first described by Arnold in 1866, whose nomenclature 
remains standard today [1]. The adrenal cortex is subdivided into three separate zones 
histologically, each responsible for the production of steroid hormones that mediate different 
aspects of stress response and homeostasis. The outermost layer, the zona glomerulosa (zG), is 
composed of cellular rosettes that secrete mineralocorticoids, like aldosterone, under control of 
the renin-angiotensin-aldosterone system (RAAS) for maintenance of electrolyte balance. The 
middle zona fasciculata (zF) consists of radial columnar cells that produce glucocorticoids, 
notably cortisol in humans and corticosterone in mice, in response to the hypothalamic-pituitary-
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adrenal (HPA) axis to mediate energy homeostasis and the mammalian stress response. The 
innermost zona reticularis (zR) contains a net-like arrangement of cells that synthesize sex-
steroid precursors, such as androstenedione and dehydroepiandrosterone (DHEA). The 
developmental establishment of the adrenal cortex occurs similarly across mammals [2], yet 
zonal differences exist between species. While humans and primates have the three 
adrenocortical zones described above, rodents lack the zR (Figure 1.1).  
 
II. Evidence for Adrenal Stem/Progenitor Cells 
Somatic stem cells are responsible for post-developmental, homeostatic maintenance of 
precursor populations and have been described for many organs [3]. Stem cells are described as 
long-lived, slow cycling, clonogenic, possessing the ability to self-renew, and having multipotent 
differentiation potential. Whereas stem cells retain the capacity to proliferate indefinitely, the 
progenitor cells that they give rise to are more committed in lineage and thought to possess 
limited replicative potential. [4]. Many studies provide evidence for adrenocortical cells with 
stem and progenitor-like capacities. 
 
Undifferentiated adrenocortical cells with limited steroidogenic capacity have been 
described across mammalian species. In mice and humans, the outermost zG layer contains both 
differentiated, aldosterone-producing cells intermingled with clusters of undifferentiated cells [5, 
6]. In rats, the zU represents a circumferential layer of undifferentiated cells between the zG and 
the zF [7]. In adrenals of the common seal (Phoca vitulina vitulina), groupings of large rounded 
cells described as ‘adrenocortical blastema’ are found adjacent to trabeculae of connective tissue 
extending from the capsule. Similar to rats, seals also possess a zona intermedia (zI) between the 
zG and zF that contains additional blastema [8]. 
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The continued proliferative capacity of the adult adrenal gland to maintain adrenal 
volume and function throughout life is consistent with the presence of a stem-like population of 
cells. Tritiated thymidine (H3-T) and BrdU pulse-chase experiments in rodents have established 
that cells proliferate in the outermost layers of the adrenal cortex and capsule [9-12]. Labeled 
cells are centripetally displaced until they reach the cortical-medullary boundary where they 
undergo apoptosis. In addition to normal homeostatic proliferation, the adrenal cortex possesses 
the ability to regenerate and repair itself following injury. As early as the 1930s, experiments 
conducted with rats demonstrated that when most of the cortex and medulla were removed 
through enucleation (leaving behind just the capsule and underlying outermost cortical layer), the 
remaining adrenal components were able to restore the bulk of adrenocortical mass within 6 
weeks of engraftment [13]. The regenerative capacity of adrenal cortex is also evident from 
reconstitution experiments where primary cultures of bovine adrenals are able to reconstitute 
functional, vascularized, steroid-secreting adrenal tissue when transplanted into 
adrenalectomized, immunocompromised mice [14, 15]. 
 
Finally, the aforementioned pulse-chase and regeneration experiments also support the 
clonal lineage of differentiated adrenocortical cells from adrenal stem cells. More recent genetic 
experiments (discussed below) have uncovered a clonal relationship between inner 
adrenocortical cells and overlying capsular and subcapsular cells (Figure 1.2). This was 
originally observed over 70 years ago with pulse-chase experiments utilizing trypan blue 
injections, where labeled capsular cells became evident within the adrenal cortex following a 2-
30 day chase period [16]. The clonal lineage of adrenocortical cells is further supported with the 
use of chimeric transgenic reporter animals that exhibit variegated transgene expression in radial 
columns throughout the adrenal cortex [17-19]. 
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III. Establishment and Maintenance of the Adrenocortical Stem Cell Niche 
A. Overview of adrenal organogenesis (Establishment) 
Cells destined to become adrenocortical cells originate from the coelomic epithelium and 
condense to form a combined adrenogonadal primordium (AGP) around three to four weeks post 
conception (wpc) in humans and embryonic day 9.0 (e9.0) in mice [20, 21]. This initial step in 
adrenal development is critically dependent on the expression of Nr5a1, which encodes the 
nuclear receptor Steroidogenic factor 1 (Sf1). Genetic loss of Nr5a1, or transcriptional regulators 
that activate Nr5a1 expression, such as Pbx1 [22], Wt1 [23, 24], and Cited2 [25, 26], results in 
complete adrenal agenesis [21]. Establishment of the AGP is followed by its separation into a 
respective adrenal and gonadal primordium, with subsequent mesenchymal cell encapsulation of 
the fetal adrenal by 9 wpc or e12.5 in mice. Concomitantly, sympathoadrenal (SA) precursors 
destined to become the adrenal medulla begin migrating into the fetal adrenal from the neural 
crest [2, 27]. Following encapsulation, the developing adrenal grows due to the emergence of 
definitive or ‘adult’ adrenocortical cells between the fetal adrenal and the capsule, while fetal 
adrenal cells begin to regress (Figure 1.2). By birth, definitive adrenocortical cells constitute the 
majority of the cortex, while only a small ring of the fetal adrenal zone remains [2]. This 
remaining layer of fetal adrenal cells regresses shortly after birth in humans but in mice 
disappears by puberty in males and the first pregnancy in females.  
 
B. Postnatal Growth and Homeostasis (Maintenance)  
Definitive adrenocortical cells emerge during late embryogenesis, with zonation of the 
adrenal cortex into distinct steroidogenic layers completed in the perinatal period with the onset 
of zG-specific expression of Cyp11b2 [28]. In humans and select nonhuman primates, the zR 
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emerges during adrenarche [29]. Homeostasis of the postnatal adrenal gland is maintained by the 
balance between proliferation at the outer cortex, centripetal displacement of differentiating 
cells, and apoptosis of cells at the cortical-medullary boundary. As discussed above, historic 
studies observed that adult adrenals contain a subset of peripheral cells with continual 
proliferative potential and the capacity to regenerate adrenal tissue. Revisiting the paradigm of 
BrdU pulse-chase experiments, recent data from the Morley laboratory established that nascently 
BrdU-labeled, proliferating cells in the outer adrenal cortex do not colocalize with steroidogenic 
markers, but become differentiated as they are centripetally displaced [12]. Additionally, a small 
fraction of label-retaining cells, consistent with a slowly cycling or relatively quiescent stem cell, 
remains in the capsule and subcapsular cortex 23 weeks post BrdU pulse [12]. These data 
provide further support that homeostatic adrenal growth is maintained by long-term retained, 
undifferentiated cells existing in both the capsule and outer adrenal cortex.  
 
C. Cell lineages 
The search for adrenocortical stem/progenitor cells has revealed very complex cell 
lineage relationships in which the precursors for adult adrenocortical cells are capsular cells and 
fetal adrenal cells that go through a capsular intermediate (Figure 1.2). The data supporting our 
current understanding of cell lineages during adrenal development and maintenance are 
discussed below. 
 
1) Fetal adrenal cells are precursors to definitive adrenocortical cells 
In addition to the adrenals and gonads, Sf1 expression is found in non-steroidogenic 
tissues such as the ventromedial hypothalamus [30], pituitary gonadotropes [31] and the spleen 
[32]. Expression of Sf1 in these organs results from distinct tissue-specific enhancers of the 
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Nr5a1 gene. Analysis of the transcriptional regulation of Nr5a1 identified a fetal adrenal 
enhancer (FAdE), whose activity is solely restricted to fetal adrenal cells. FAdE expression is 
initiated by complexes of the homeobox proteins Pbx1, Pknox1, and Hox transcription factors, 
and later maintained by Sf1 itself [33]. Lineage-tracing experiments utilizing FAdE-driven Cre 
recombinase (FAdE-Ad4bp-Cre) revealed that FAdE-expressing cells were precursors to most, if 
not all, Sf1+ cells in the adult adrenal cortex [34]. Interestingly, a temporal window existed in 
which fetal adrenal cells could serve as precursors for definitive adrenal cells. Using a FAdE-
CreERT2 inducible allele, only FAdE-expressing cells marked prior to fetal adrenal 
encapsulation could serve as precursors for adult adrenal cells. When induced on or after e14.5, 
FAdE-derived adult adrenocortical cells were no longer detected [34]. These data suggest that an 
initial population of fetal adrenal cells contributes to lineage of adult adrenocortical cells only 
early in adrenal development. 
 
2) Sf1-negative capsular cells give rise to Sf1-positive definitive adrenocortical cells 
Trypan blue lineage tracing experiments discussed above suggested that adrenocortical 
cells are derived from the overlying Sf1-negative (-) mesenchymal capsule [16]. More recently, 
data from three independent laboratories studying the Hedgehog (Hh) pathway in the adrenal 
gland also provided evidence for this phenomenon. In mammals, a family of secreted Hh 
molecules, Sonic (Shh), Desert (Dhh) and Indian (Ihh), bind to the cell surface receptor Patched1 
(Ptch1). In the absence of Hh ligands, Ptch1 inhibits the positive signal transducer Smoothened 
(Smo), resulting in proteolytic processing of Gli transcription factors to their co-repressor form. 
Hh binding to Ptch1 relieves inhibition of Smo resulting in downstream signaling that inhibits 
proteolysis of Gli proteins. Hh target genes, including Gli1 and Ptch1, are induced by active Gli 
transcription factors and are important for feedback regulation. In the adrenal gland, Shh is 
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expressed in peripheral Sf1-positive (+) adrenocortical cells from e12.5 onward [35-37] (Figure 
1.3). These cells rarely colocalize with steroidogenic markers during development or postnatal 
life and therefore are relatively undifferentiated [35]. The Shh-receiving cells are contained 
within an inner layer of Sf1- capsular cells, which express Smo, Ptch1 and Gli1 [35-37]. Cell 
lineage analysis with ROSA26-YFP reporter mice crossed with mice harboring a Cre 
recombinase replacing the endogenous Shh locus (Shhgfpcre:R26-YFP) revealed that postnatally, 
all cells of the cortex (but not capsule or medulla) were derived from Shh-expressing fetal cells 
[35]. Further experiments utilizing an inducible Shh-Cre allele crossed to GFP reporter mice (Shh 
CreT2:R26 mR/mG) showed that shortly after labeling, Shh-expressing cells remain restricted to 
the peripheral cortex [35]. Over time, these cells and their descendents form clonal, radial stripes 
that extend deep into the cortex and colocalize with steroidogenic cells of both the zG and zF. In 
addition to Shh-expressing cells, the lineage of Gli1+ (Shh-receiving) cells was also investigated. 
Employing an inducible Gli1-CreERT2 allele, investigators demonstrated that during adrenal 
development, Sf1-;Gli1+ capsular cells gave rise to Sf1+;Gli1- undifferentiated Shh+ cells, as 
well as Sf1+; Gli1- steroidogenic cells [35]. Postnatal lineage tracing experiments unveiled 
similar results. Collectively, these data suggest that Sf1-;Gli1+ capsular cells serve as 
precursor/stem cells to Sf1+, Shh+ undifferentiated progenitors and differentiated steroidogenic 
cells during adrenal organogenesis and postnatal maintenance.  
 
 Pathological stress can engage different pools of stem/precursor cells to participate in 
tissue regeneration in a variety of organ systems [38]. During normal maintenance of the adult 
cortex, Wt1+ mesenchymal capsular cells can contribute to the steroidogenic lineage, yet only 
infrequently [39]. However, following gonadectomy, engagement of the Wt1+ capsular 
population is more robust. Utilizing Wt1:CreERT2, ROSAmG/mT mice, cords of GFP+ Wt1 
  8 
descendents give rise to Wt1-; Sf1+ cells that express the gonadal genes Cyp17 and luteinizing 
hormone receptor (Lhr) [39]. These data indicate that the capsule contains several populations of 
multipotent adrenocortical stem/progenitor cells that have the capacity to differentiate into 
adrenal or gonadal cells in response to differing endocrine stressors.  
 
3) Sf1+ fetal adrenal cells give rise to Sf1-, Gli1+ capsular cells 
Data discussed above indicates that fetal adrenal cells expressing Nr5a1 from FAdE and 
Sf1- capsular cells both serve as precursors to definitive adrenocortical cells. A unifying model 
integrating these observations would predict that a subpopulation of fetal adrenal cells could 
contribute to the forming capsule and switch off Nr5a1 expression [40]. These cells or their 
descendants would express Gli1 and give rise to adult adrenocortical cells expressing Nr5a1 
from the definitive enhancer as demonstrated previously [35]. Experimental evidence for this 
model recently emerged from our laboratory. To investigate whether FAdE-expressing fetal 
adrenal cells gave rise to capsular cells, FAdE-Ad4bp-Cre mice (described above) were crossed 
with ROSA26-tdTomato/eGFP reporter mice (FAdE-Ad4bp-Cre:R26RmT/mG) and transgenic 
adrenals were evaluated at e18.5 and adulthood. In FAdE-Ad4bp-Cre:R26RmT/mG adrenals, GFP+ 
descendents from FAdE-expressing cells colocalize with steroidogenic cells of the adult adrenal 
cortex as observed previously [34]. Additionally, a subset of GFP+ cells reside within the Sf1- 
capsule [41]. When FAdE-Ad4bp-Cre:R26RmT/mG mice were bred with Gli1-LacZ reporter mice, 
FAdE-Ad4bp-Cre:R26RmT/mG:Gli1-LacZ adrenals exhibited capsular cells that co-expressed GFP 
and LacZ [41]. These data collectively demonstrate that descendants from fetal adrenal cells 
extinguish Sf1 expression and contribute to the population of Sf1-; Gli1+ capsular cells (Figure 
1.2). These data unify the seemingly disparate cell lineage relationships of adult adrenocortical 
precursors.  
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4) Zonation and lineage conversion of differentiated adrenocortical cells  
While definitive adrenocortical cells arise during embryogenesis, zonation of the adrenal 
cortex into distinct steroidogenic layers occurs perinatally and is relatively static under normal 
physiological conditions. Several models explain the derivation of differentiated, steroidogenic 
cells of each layer. Gottschau first proposed the centripetal migration model in which progenitor 
cells in the peripheral cortex first differentiate into mineralocorticoid-producing cells in the zG 
and upon centripetal displacement transform into glucocorticoid-producing cells of the zF [42]. 
Based on the disparate effects of hypophysectomy on the zG and zF, along with the distinct 
functions of the steroids produced from these zones, a separate model hypothesized that each 
steroidogenic layer contains its own progenitor pool [43]. H3-T, BrdU and trypan blue pulse-
chase experiments support the centripetal migration model, however, none of these studies 
directly tested lineage conversion of a zG to zF cell. Recently, a series of zG cell lineage tracing 
experiments provided genetic evidence for the conversion of zG cells into zF cells. In mice that 
contain Cre recombinase inserted into the Cyp11b2 locus (ASCre), Cre is expressed in terminally 
differentiated cells of the zG [44]. When crossed with R26RmT/mG reporter mice (described 
above), GFP+ cells appear in the zG the outset of Cyp11b2 expression and eventually label the 
entire zG [44]. Cyp11b1-expressing cells in the zF (that do not express Cyp11b2) become GFP+ 
over time, indicating these cells underwent lineage conversion from a zG cell. By twelve weeks 
of age, nearly the entire cortex is GFP+ [44]. This phenomenon also occurs under forced 
homeostatic maintenance of the cortex, namely regeneration following dexamethasone (dex) 
induced zF atrophy. Eight weeks following dex withdrawal, AS+/Cre::R26R+/mTmG exhibited GFP+ 
zF cells [44], indicating lineage conversion of zG to zF still occurs under this homeostatic 
paradigm. 
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IV. Factors involved in regulation of adrenal stem cells 
A. Transcription factors 
1) Sf1.  
As introduced above, Sf1 is an essential regulator of adrenal development as well as 
steroidogenic function. Both the Parker and Morohashi laboratories originally identified Sf1 
(also known as Ad4-binding protein, Ad4bp) as the nuclear receptor that activates transcription 
of the steroidogenic enzymes responsible for catalyzing steroid biosynthesis [45, 46]. Shortly 
thereafter, the importance of Sf1 in adrenal specification and growth became evident utilizing 
genetic loss-of-function studies in vivo. Sf1 expression initiates at e9.0 in the urogenital ridge, 
specifying precursors of the steroidogenic lineage and forming the AGP [47]. Mice globally 
deficient for Sf1 exhibit degeneration of the AGP due to apoptosis between e11.5 and e12.0, 
resulting in agenesis of the adrenals and gonads [21]. Unlike Sf1 knockout animals, mice 
heterozygous for Sf1 survive to adulthood yet possess smaller, hypertrophic adrenals that show 
reduced capacity for corticosterone production when stressed [48]. Similarly, humans 
heterozygous for Sf1 mutations exhibit primary adrenal failure and gonadal dysgenesis (see [49] 
for review). In a genetic model where Sf1 overexpression is mediated by the fetal adrenal 
enhancer of Nr5a1, mice exhibit ectopic formation of adrenal tissue throughout the thoracic 
cavity [50]. Similarly, forced expression of Sf1 in embryonic [51] and mesenchymal stem cells 
[52] is sufficient to promote steroidogenic cell differentiation in vitro. These data collectively 
demonstrate the importance of Sf1 in specification and differentiation of steroidogenic 
precursors. Additionally, Sf1 heterozygotes are unable to mount a compensatory growth 
response following unilateral adrenalectomy due to lack of peripheral adrenal cell proliferation 
[53]. These data, coupled with studies demonstrating increased subcapsular proliferation in mice 
  11 
with transgenic overexpression of Sf1 [54], highlight a critical role for Sf1 in the regulation of 
adrenocortical cell proliferation in addition to differentiation. How does Sf1 mediate the 
seemingly opposing tasks of proliferation vs. differentiation?  Regulation of the transcriptional 
activity of Sf1 by post-translational modifications and/or stimulatory and inhibitory ligands are 
posited to dictate what genetic programs are enacted by Sf1. Post translational modification of 
Sf1 has been extensively studied and reviewed elsewhere [55, 56]. The role of these 
modifications in homeostatic maintenance is an area of active investigation.  
 
2) Dax1.  
Nr0b1 encodes Dax1 (Dosage-sensitive sex reversal, Adrenal Hypoplasia Congenita 
(AHC) critical region on the X chromosome gene 1), an atypical nuclear receptor (NR) found 
mutated or deleted in patients afflicted with X-linked AHC. Dax1 lacks a classical NR DNA-
binding domain, instead containing three and a half repeated stretches of glycine and alanine rich 
regions [57]. Initial reports demonstrated that Dax1 functioned as a negative regulator of Sf1-
mediated transcription [58] and subsequently these findings were extended to other NRs as well 
[59]. Dax1 recruits the corepressors NCoR and Alien for transcriptional inhibition [60, 61], 
however data suggests Dax1 has a dose-dependent coactivator capacity [62]. Dax1 inhibits Sf1-
mediated steroidogenesis in vitro and in vivo [63], but also directly represses Star by binding to 
hairpin structures present in the promoter region [64]. These early studies were performed in cell 
culture systems and the role of Dax1 in vivo remained elusive for some time. It was unclear 
whether Dax1 exerted its inhibitory actions on steroidogenesis in a differentiated cell or in a 
progenitor cell where steroidogenesis was uniquely downregulated. Indeed, a number of studies 
have shown that Dax1 is essential to maintain ES cell pluripotency [65-68]. In the adult adrenal 
cortex, Dax1 is critical for maintenance of progenitor cells as Dax1 deficient mice display 
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worsening adrenal dysplasia with age [69]. When compared to wildtype littermates, Dax1 
knockout mice exhibit enhanced steroidogenesis and proliferation at early ages, with progressive 
loss of proliferating cells over time [69]. These data suggest that without Dax1, adrenal 
progenitors precociously differentiate leading to their continued depletion, ultimately 
manifesting in adrenal failure in these animals.  
 
B. Paracrine signaling pathways 
1) Wnt Pathway.  
The mammalian Wingless-Type MMTV Integration Site (Wnt) pathway is a paracrine 
signaling pathway critically involved in development and stem cell maintenance in multiple 
organ systems [70]. Secreted Wnt molecules bind to a variety of receptors (including Frizzleds 
(Fzd), RORs and RYKs) to elicit distinct downstream signaling through the canonical/beta 
catenin (βcat) pathway and/or the noncanonical/planar cell polarity and calcium signaling 
pathways [71]. For activation of the canonical pathway, Wnts bind to Fzd receptors resulting in 
the inactivation of multi-protein complex that promotes the destruction of the transcription factor 
βcat. Once freed from the destruction complex, βcat enters the nucleus and transactivates Wnt-
responsive genes through interaction with DNA-bound TCF/LEF transcriptional regulators. The 
developing adrenal exhibits βcat expression as early as e12.5 [72]. Employing transgenic 
reporter mice, active canonical Wnt/βcat signaling is evident in a few scattered cells in the 
periphery of the gland at this time. By e18.5, Wnt/βcat signaling is more broadly restricted to the 
outer subcapsular region of the cortex [72]. To ablate βcat expression in adrenocortical cells, 
Kim et al. crossed Ctnnb1tm2kem mice that have floxed βcat alleles with Sf1/Crehigh mice, which 
contain five copies of the Sf1/Cre transgene resulting in high Cre expression in Sf1+ cells [72]. 
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Adrenal development initiates in the absence of βcat, however, adrenocortical cells exhibit a 
remarkable loss of proliferation between e12.5-e14.5 with disappearance of the entire gland by 
e18.5 [72]. Sf1/Crelow mice only contain one copy of the Sf1/Cre transgene and exhibit 
inefficient recombination. In Sf1/Crelow:Ctnnb1tm2kem mice, a subset of cells escapes 
recombination leading to an overall 50% decrease in βcat-mediated Wnt signaling [72]. 
Sf1/Crelow:Ctnnb1tm2kem adrenals develop relatively normally until 15 weeks of age, where after 
progressive thinning of the adrenal cortex, marked by loss of Sf1+ cells, results in adrenal failure 
by 45 weeks of age [72]. It is interesting to note that Nr0b1/Dax1 (discussed above) is a βcat 
target gene and Dax1 deficient adrenals in part phenocopy Sf1/Crelow:Ctnnb1tm2kem adrenals [69]. 
Data emerging from the Val laboratory suggests βcat contributes to differentiation of zG cells 
through the indirect regulation of aldosterone production [73]. Collectively, these data support a 
role for Wnt/βcat signaling in maintenance and commitment of the adrenal progenitor pool. 
 
The Wnt4 ligand is expressed in the developing adrenal as early as e11.5, with restricted 
expression in the periphery of the cortex observable by e14.5 [5]. It remains unclear whether 
Wnt4 expression is a cause or consequence of the activated canonical Wnt pathway, as it has 
been shown to be genetically downstream of βcat in other tissues [74, 75]. In humans, Wnt4 
mutations result in SERKAL syndrome, an autosomal-recessive disorder that includes female sex 
reversal and dysgenesis of the kidneys, lungs and adrenal glands [76]. SERKAL-afflicted fetuses 
exhibit reduced adrenal size but relatively normal histology [76]. In contrast, mice globally 
deficient for Wnt4 have relatively similar adrenal size and morphology during development, but 
exhibit reduced Cyp11b2 expression at birth resulting in less aldosterone production [5]. Wnt4 
knockout mice also contain ectopic adrenocortical cells at the anterior tips of the gonads, the 
  14 
region closest in proximity to the forming adrenal glands. Given the shared lineage between the 
adrenal and gonad, these data suggest that Wnt4 regulates adrenal cell homing or specification 
during separation of the AGP in early adrenal development [5, 77].  
 
2) Shh Pathway.  
Shh signaling is implicated in developmental patterning and stem cell biology in many 
tissues, from flies to humans [78]. Evidence for the importance of Shh signaling in adrenal 
development arose from the discovery that frameshift mutations that result in truncation of Gli3 
into a constitutive repressor are the underlying cause of Pallister Hall syndrome (PHS). PHS is 
characterized by a constellation of congenital anomalies including polydactyly, hypothalamic 
hamartoma, kidney abnormalities and adrenal insufficiency. A genetic mouse model of PHS 
utilizing a truncated Gli3Δ699 allele has lead to discrepant findings; one study reported these 
mice displayed adrenal aplasia [79], while Laufer et al. found no adrenal malformations [80]. 
Nonetheless, recent reports have highlighted a critical role for the Shh in adrenocortical 
progenitor biology (see above). Mice with global Shh ablation, as well as conditional ablation of 
Shh in steroidogenic cells, exhibit hypoplastic adrenals embryonically due to reduced cortical 
and capsular cell proliferation [36, 37]. Adult Sf1/Cre:Shhfl/- exhibit hypertrophic cells yet retain 
the capacity for steroid secretion [37]. Despite smaller adrenal volume in Shh deficient mice, 
adrenal histology and organization is comparable to wildtype counterparts, indicating 
adrenocortical encapsulation and zonation, as well as migration of medullary cells, does not rely 
on Shh signaling. However, Sf1/Cre:Shhfl/-  embryonic and adult adrenals possess markedly 
thinner capsules compared to wildtype [35, 37]. Coupled with the observation that Shh deficient 
mice have reduced capsular proliferation, these data indicate Shh is may be a regulator of 
mitogenic signaling for capsular stem/progenitor cells.  
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3) FGF Signaling.  
The complexity of the fibroblast growth factor (FGF) signaling pathway is due to the 
diversity of ligands, receptors and their isoforms, as well as the intracellular signaling cascades 
that participate in FGF signal transduction. Binding of FGFs to FGF receptor tyrosine kinases 
(FGFRs) is facilitated by transmembrane heparan sulfate proteoglycans (HSPG). Ligand binding 
promotes FGFR dimerization and autophosphorylation, which can elicit multiple signaling 
pathways downstream, including JAK/STAT, PLCγ, PI3K and Erk pathways [81]. Both the 
adrenal capsule and cortex express components of the FGF pathway (Figure 1.3). FGF2 and 
FGF9 expressed in the capsule signal to FGFR1 IIIc and FGFR2 IIIc expressed in both the cortex 
and capsule [82, 83]. FGF1 secreted from the cortex is thought to elicit signaling from FGFR1 
IIIc, FGFR2 IIIb and IIIc expressed in both compartments [82, 83]. Ablation of FGFR2 in the 
steroidogenic cell lineage results in adrenal hypoplasia observable by e15.5 [84]. The effects of 
FGFR2 deletion are predicted to be solely due to loss of the IIIb isoform as global deletion of 
FGFR2 IIIb results in embryonic adrenal hypoplasia [82, 85], whereas FGFR2 IIIc knockout 
mice have no discernable adrenal phenotype at postnatal day 2 [86]. Adrenal hypoplasia evident 
in FGFR IIIb deficient mice results from reduced cortical proliferation during embryogenesis 
[82], demonstrating a requirement for mitogenic FGF signaling for proper adrenal development. 
FGFs also exert mitogenic effects during postnatal adrenal maintenance. FGF2 elicits 
proliferation in both primary adrenocortical cultures and tumor cell lines [87, 88]. Adrenal re-
growth under the paradigms of reconstitution by primary culture or compensatory growth 
following unilateral adrenalectomy is critically dependent on the pro-proliferative and 
angiogenic properties of FGFs [15, 89, 90].  
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4) TGFβ signaling and Inhibin.  
The transforming growth factor beta (TGFβ) signaling pathway elicits a wide variety of 
cellular processes and is involved in maintenance and differentiation of stem cells [91]. The 
TGFβ superfamily consists of a diverse array of ligands, including (but not limited to) bone 
morphogenetic proteins (BMPs), growth and differentiation factors (GDFs), activins and 
inhibins. Ligand binding to TGFβ type II receptors promotes phosphorylation of type I receptors 
and results in phosphorylation and nuclear translocation of Smad proteins that modulate 
transcription of target genes. Activins and inhibins are present throughout the fetal and adult 
adrenal cortex [92] and profoundly influence adrenocortical differentiation. Activins augment 
Adrenocorticotropic hormone (ACTH)-induced steroidogenesis in fetal adrenal cells and 
stimulate Angiotensin II (AII) and ACTH-induced aldosterone production in adult adrenal cells 
[92, 93]. Unlike activins, it is unclear if inhibins directly affect adrenal steroidogenesis [94]; 
however, Inhibin-α (Inhα) has been demonstrated to greatly impact adrenal progenitor biology. 
Following gonadectomy, Inhα deficient mice develop adrenocortical tumors [95] dependent on 
high levels of circulating luteinizing hormone (LH) [96]. Loss of Inhα results in constitutive 
Smad3 activation with subsequent formation of neoplastic cells in the adrenal that express 
ovarian theca and granulosa cell markers, LH receptor (Lhr) and anti-Mullerian hormone (Amh), 
respectively [97]. Ectopic ovarian differentiation of adrenal cells results from the LH-induced 
switch from adrenal-specific Gata6 expression to gonadal-restricted Gata4 expression only in the 
context of Inhα deficiency [97]. Altogether, these data establish a role for Inhibin-α in the 
maintenance the adrenal fate of adrenocortical progenitor cells. 
 
5) IGF Signaling.  
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The insulin-like growth factor (IGF) signaling pathway has been implicated in both the 
growth and differentiation of the adrenal cortex. The IGF family consists of two ligands 
structurally similar to proinsulin, IGF1 and IGF2. These secreted proteins interact with IGF1-
receptor (IGF1R), a receptor tyrosine kinase structurally similar to the insulin receptor, to elicit 
pro-growth and survival signaling through MAPK and/or PI3K/Akt pathways [98]. IGF2R is 
distinct from IGF1R; it does not contain a tyrosine kinase domain and acts as a molecular sink to 
restrict the bioavailability of IGF2 [98]. Six IGF-binding proteins (IGFBPs) bind to and exert 
stimulatory or inhibitory effects on IGFs, however their actions in the adrenal are poorly 
understood. All components of the IGF pathway are expressed throughout the adrenal across 
mammalian species [2] (Figure 1.3). IGFs exert strong mitogenic effects on fetal and adult 
adrenal cells [99, 100].  IGF2 is highly expressed in the fetal adrenal however in the adult 
adrenal IGF2 expression is decreased and equivalent with IGF1 levels [98]. IGFRs are expressed 
throughout all zones of the human adrenal cortex, with enrichment of IGF1R in the subcapsular 
region [101]. Mice deficient for both the insulin receptor (Insr) and Igf1r exhibit gonadal 
dysgenesis, male-to-female sex reversal and adrenal aplasia [102]. Adrenal agenesis is evident by 
e16.5 and is likely due to global loss of cell proliferation throughout the genital ridge and AGP 
as early as e10.5 [102]. Insr, Igf1r double knockout mice also contain almost half the number of 
Sf1+ cells in the AGP at e.11.5, as well as reduced Nr5a1 expression. These data collectively 
indicate that IGF signaling is a potent adrenal mitogen and is critical for adrenal specification 
early in development. Additionally, IGFs augment basal and ACTH-induced steroidogenesis in 
both fetal and adult adrenal cells in vitro [103], suggesting a role for IGF signaling in 
adrenocortical differentiation in addition to adrenal proliferation. 
 
C. Endocrine Signaling  
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The peptide hormones AII and ACTH mediate different aspects of endocrine homeostasis 
through regulation of adrenocortical steroidogenesis and differentiation (Figure 1.3). Under the 
control of RAAS, AII promotes aldosterone production through activation of phospholipase C 
(PLC), calcium signaling and protein kinase C (PKC) (see [104] for in-depth review). In 
contrast, proopiomelanocortin (POMC)-derived ACTH, under regulation by the HPA axis, 
induces glucocorticoid synthesis by stimulating cyclic-AMP/Protein kinase A (PKA) and 
MAPK/Erk signal transduction pathways (for in depth review, see [105]). Mice deficient for AII 
type 1 receptors (Agtr1a-/-; Agtr1b-/-), the ACTH receptor (Mc2r) or Pomc exhibit normal 
adrenal histology at birth [106-108], indicating AII and ACTH are dispensable for normal fetal 
adrenal development. However, these endocrine signals profoundly influence adrenocortical 
remodeling and maintenance during adult life. Activation of the RAAS and the HPA axis affect 
adrenal architecture similarly; initial differentiation and hypertrophy of steroidogenic cells 
occurs acutely, with chronic stimulation resulting in increased proliferation through mechanisms 
that are not well established [109]. Rats subjected to a low salt diet exhibited hypertrophic cells 
that had increased Cyp11b2 expression in the zG over the initial 3 days, followed by hyperplasia 
peaking 3-5 days after commencement of diet [110]. It is predicted the increase in Cyp11b2+ 
cells prior to proliferation is the direct result of differentiation of Shh-expressing cells into zG 
cells (see above), followed by proliferation for progenitor replacement. In accord with this 
notion, rats subsisting on a low salt diet for 3 days gained Cyp11b2-expressing cells without 
induction of proliferation, commensurate with a ~50% reduction in Shh expression [111]. 
Additionally, the bulk of replicating cells under chronic RAAS or ACTH stimulation initially 
reside within the undifferentiated zU before extending to the other zones [110, 112]. Conflicting 
data exist on whether ACTH is mitogenic in itself [113]. Rather, it has been suggested that 
ACTH stimulates expression of growth factors, such as IGF2 [114, 115]. 
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V. Summary  
While a number of signaling pathways have been shown to participate in the growth and 
homeostatic maintenance of the adrenal cortex, it is unclear how paracrine and endocrine signals 
are spatially and temporally integrated. In this thesis, the role of the Wnt/βcat pathway in 
regulation of adrenal progenitor biology is explored. In chapter two, characterization the Wnt-
responsive population in vivo finds that Wnt-responsive cells are heterogeneous, supporting the 
notion that Wnt signaling plays diverse roles in the adrenal cortex. Utilizing an adrenocortical 
cell model, I identified a novel aspect of the relationship between βcat and Sf1, wherein βcat 
inhibits Sf1-mediated steroidogenesis. Gene expression profiling in vitro and in vivo uncovered 
novel genes regulated by the Wnt/βcat pathway in the adrenal cortex. One such gene, Ccdc80, 
encodes the secreted factor that also participates in suppression of zF cell steroidogenesis. These 
data implicate Wnt/βcat signaling in the promotion of unidirectional differentiation of 
adrenocortical progenitors into zG cells, and not zF cells. Collectively, this dissertation provides 
mechanistic insight into how Wnt signaling contributes to adrenal homeostasis. 
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FIGURES 
 
Figure 1.1: Histology of the mouse adrenal. 
Transverse section of a wildtype adult mouse adrenal stained with hematoxylin and eosin. 
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Figure 1.2: Cell lineages in adrenal development and homeostasis. 
 
(A) Multiple cell lineages contribute to the adrenal gland. Neural crest cells (red) are precursors 
to catecholamine-secreting cells of the adrenal medulla. Wt1-expressing mesenchymal cells 
contribute to the adrenal capsule (orange). Fetal adrenal cells (blue) give rise to a subpopulation 
of capsular cells that express Gli1 (blue/white). Gli1-expressing capsular cells give rise to 
undifferentiated Shh-producing cells (green) and differentiated steroidogenic adrenocortical cells 
(yellow) of the adult gland. Shh-producing cells give rise to and/or differentiate into 
steroidogenic cells of the definitive cortex. Wt1-expressing cells (orange) give rise to 
differentiated cells of adult cortex that no longer express Wt1. (B) The tissues represented in C. 
(C) Adrenal organogenesis begins when adrenogonadal primordia (AGP) form and separate into 
fetal adrenals and fetal gonads. Cells from the neural crest infiltrate the fetal adrenal gland to 
form the medulla, while mesenchymal cells participate in encapsulation. Fetal adrenal cells give 
rise to a portion of adrenal capsule. As the definitive cortex replaces the fetal cortex, Gli1-
expressing capsular cells serve as precursors to Shh-expressing progenitors and steroidogenic 
adrenocortical cells. Wt1+ cells also contribute to the cortex, albeit infrequently. Upon 
completion of development, the capsular and subcapsular progenitor cells are retained 
throughout adulthood and maintain homeostasis of the definitive adrenal cortex. Adapted from 
[41].  
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Figure 1.3: Signaling pathways that participate in various aspects of adrenal biology. 
 
AII and ACTH are endocrine signals (black arrows) that stimulate steroidogenesis in 
differentiated cells of the zG (grey) and zF (green), respectively. Undifferentiated progenitor 
cells (red) secrete Shh ligands (red arrow) that act on cells within the adrenal capsule (orange). 
Wnt ligands (blue arrow) are received by cells of the zG, are critical for maintenance of 
adrenocortical progenitors, and indirectly regulate aldosterone production. FGFs (yellow arrows) 
are secreted from and received by both the capsule and cortex and may be involved in regulation 
of proliferation. During adulthood, IGFs are expressed in the capsule, act on the cortex to 
promote proliferation, and may participate in steroidogenesis.  
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CHAPTER II: WNT SIGNALING INHIBITS ADRENOCORTICAL 
STEROIDOGENESIS BY CELL-AUTONOMOUS AND NON-CELL-AUTONOMOUS 
MECHANISMS 
 
INTRODUCTION 
The adrenal cortex synthesizes and secretes steroid hormones necessary for life. The 
adrenal is zonated into distinct steroidogenic layers responsible for the production of steroids 
under the control of differing physiological stimuli. In the outer most subcapsular layer, the zona 
glomerulosa (zG), mineralocorticoids such as aldosterone are produced under the control of the 
renin-angiotensin system. The inner zona fasciculata (zF) produces glucocorticoids, such as 
cortisol in humans and corticosterone in mice that coordinate the mammalian stress response 
regulated by the hypothalamic-pituitary-adrenal (HPA) axis.  
 
The static adrenocortical zonation is intriguing given the exceptionally dynamic nature of 
the adrenal cortex; cells proliferate at its periphery, differentiate into steroidogenic cells that are 
displaced centripetally until they eventually turnover at the adrenocortical-medullary boundary. 
Cell turnover requires replenishment of adrenocortical cells from a somatic stem/progenitor cell 
pool for maintenance of adrenal tissue. Historically, it has been debated whether each 
steroidogenic zone contains its own progenitor cell, or whether a common adrenocortical 
progenitor within the periphery of the cortex changes its fate as it is centripetally displaced 
throughout life. In recent years, several studies have provided evidence for the latter. Work by 
King et al. demonstrated that Shh-producing cells that reside within the subcapsular region serve 
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as a common progenitor cell for steroidogenic lineages. Using lineage tracing, relatively 
undifferentiated Shh-producing cells become steroidogenic cells of both adrenocortical zones 
over time [1]. Additionally, utilizing an Aldosterone Synthase-Cre recombinase in cell lineage 
tracing experiments of zG cells, Freedman et al. demonstrated that under normal conditions all 
zF cells are derived from zG cells [2]. Collectively, these data suggest unidirectional 
differentiation of adrenocortical progenitors first to zG cells that undergo conversion into zF 
cells as they transit through the cortex. However, how progenitor cells are maintained in the 
subcapsular region, as well as how unidirectional differentiation is regulated is not well 
understood. 
 
 Canonical Wnt signaling is a paracrine signaling pathway implicated in progenitor cell 
biology in a variety of organ systems, including the adrenal cortex. In the absence of Wnt 
ligands, the pathway is inactive, resulting from sequestration of the transcriptional regulator beta 
catenin (βcat) into cytoplasmic destruction complexes composed of Axin, adenomatous 
polyposis coli (APC), glycogen synthase kinase 3β (GSK3β), casein kinase 1α (CKIα) and other 
components. Phosphorylation of βcat by GSK3β and CKIα results in its ubiquitination by β-
transductin-repeat-containing protein (β-TrCP) and subsequent degradation by the proteasome. 
Wnt ligands binding to Frizzled (Fzd) receptors with Lrp5/6 co-receptors results in the inhibition 
of the destruction complex, leading to βcat stabilization and nuclear translocation. βcat then 
activates Wnt-responsive genes by binding to TCF/LEF transcription factors at gene enhancers. 
The Wnt/βcat pathway has been previously implicated in the homeostatic maintenance of the 
adrenal gland [3]. Partial loss-of-function of βcat in the adrenal cortex leads to depletion of 
adrenocortical cells upon aging, highlighting a critical role for βcat in maintenance of the 
progenitor cells in the adrenal cortex [3]. Wnt signaling maintains adrenocortical progenitors in 
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part through the activation of the βcat target gene, Nr0b1, dosage-sensitive sex reversal, adrenal 
hypoplasia congenita (AHC) critical region on the X chromosome, gene 1 (Dax1) [4]. Dax1 is an 
orphan nuclear receptor implicated in maintaining the pluripotency of embryonic stem cells [5]. 
Dax1 knockout adrenals display enhanced steroidogenesis in early ages with adrenocortical 
failure at late ages [6], consistent with the precocious differentiation of adrenocortical 
progenitors in the absence of Dax1 resulting in premature depletion of the progenitor cell pool. 
Interestingly, Wnt signaling has also recently been implicated in zG cell differentiation. A study 
by Berthon et al. indicates that βcat indirectly promotes aldosterone production by increasing 
expression of the Angiotensin receptor (At1r) and Nr4a1/2 genes, which stimulate the expression 
of Cyp11b2, the terminal enzyme in aldosterone biosynthesis [7]. It remains unclear whether 
Wnt signaling directly influences zF cell differentiation. 
 
 In this study, we report that Wnt-responsive cells colocalize with markers of 
adrenocortical progenitors and differentiated cells of the zG but not the zF. Stimulation of βcat 
activity in vitro inhibits zF cell differentiation by suppressing steroidogenesis through Sf1-
dependent mechanisms as well as through the induction of a new βcat-regulated gene, Ccdc80. 
Our study provides insight into how Wnt signaling maintains the undifferentiated state of adrenal 
progenitor cells through inhibition of steroidogenesis. Additionally, our data indicate that βcat 
inhibits the zF cell phenotype, supporting a role for Wnt signaling in the unidirectional 
differentiation of adrenal progenitors into zG cells. 
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MATERIALS AND METHODS 
Mice 
All animal experiments were carried out in accordance with protocols approved by the 
University Committee on Use and Care of Animals at the University of Michigan. Reporter mice 
used in these studies have been described elsewhere. TCF/Lef:H2B-GFP mice [8] were obtained 
from JAX laboratories. ShhLacZ mice [9] were obtained from the laboratory of Andrzej Dlugosz 
at the University of Michigan. Sf1:eGFP mice [10] were obtained from the laboratory of the late 
Keith Parker.  
 
Immunofluorescence  
Adrenals from 6 week old male Tcf/Lef:H2B-GFP; ShhLacZ mice were fixed for 4 h with 
4% paraformaldehyde (PFA), dehydrated in graded ethanol solutions and paraffin-embedded. 
For BrdU labeling in vivo, mice were intraperitoneally injected with BrdU Labeling Reagent 
(Life Technologies, Carlsbad, CA) 1mL/100g body weight, sacrificed 2 h later and processed as 
above. For immunofluorescence analyses, adrenal sections (6 µm) were boiled in 10 mM citric 
acid (pH 2 or pH 6) for 10 min followed by 20 min cooling for antigen retrieval. Slides were 
washed with phosphate-buffered saline (PBS) and blocked with 2% non-fat dry milk in PBS with 
5% goat serum (Thermo Scientific, Wilmington, DE) for 1 h followed by primary antibody 
incubation at 4°C overnight. Slides were washed with tris-buffered saline with 0.1% Tween 
(TBS-T), incubated with secondary antibodies for 1 h at room temperature followed by nuclear 
counterstaining with DAPI and mounted using ProLong Gold Antifade Reagent (Life 
Technologies, Carlsbad, CA). Slides were cured overnight and fluorescence microscopy was 
performed on a Zeiss ApoTome microscope utilizing an AxioCam MRm (Carl Zeiss, 
Thornwood, NY). Primary antibodies: rabbit α-GFP 1:200 (Life Technologies, Carlsbad, CA), 
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chicken α-LacZ 1:1000 (Abcam, Cambridge, MA), mouse α-PCNA 1:500 (Santa Cruz 
Biotechnology, Inc., Dallas, TX), sheep α-BrdU 1:230 (Abcam, Cambridge, MA), mouse α-
Cyp11b1 and mouse α-Cyp11b2 1:50 (generous gifts from Dr. C. Gomez-Sanchez) and chicken 
α-GFP 1:1500 (Abcam, Cambridge, MA). Secondary antibodies: goat α-rabbit Alexa Fluor 488, 
goat α-mouse Dylight 488, donkey α-chicken Dylight 488, goat α-chicken Dylight 549, donkey 
α-sheep Cy3, goat α-mouse Dylight 649, donkey α-rabbit Dylight 649 - all used at 1:800 (all 
obtained from Jackson ImmunoResearch, West Grove, PA). For quantification of 
immunofluorescence data, a total cell count per population (GFP+, LacZ+ or PCNA+) was 
obtained from 3 separate adrenal sections corresponding to distinct adrenal regions. The number 
of double-positive GFP+/LacZ+, GFP+/PCNA+ or LacZ+/PCNA+ cells was divided by the total 
number of GFP+, LacZ+ or PCNA+ cells. Data were averaged from 7 different animals.  
 
Cell culture and Reagents 
ATCL7 and 293T cells were grown under standard conditions at 37°C with 5% CO2. 
Growth medium for ATCL7 cells was DMEM:F12 containing 2.5% fetal bovine serum (FBS), 
2.5% horse serum (HS), 100U/mL pencillin/streptomycin (P/S), 1% Insulin-Transferrin-
Selenium X (all obtained from Life Technologies, Carlsbad, CA). For treatment experiments, 
cells were grown in low serum media (same as normal growth media except with 0.025% FBS 
and 0.025% HS). 293T cells were grown in DMEM with 10% FBS and 100U/mL P/S. 6-
bromoindirubin-3′-oxime (BIO), ACTH (human, rat N-terminal fragment 1-24), and DMSO 
were obtained from Sigma-Aldrich (St Louis, MO). 
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Immunocytochemistry 
ATCL7 cells were plated at a density of 105 cells per well on chamber slides (Lab-Tek). 
After 24 h, cells were treated with 0.5 µM BIO or DMSO overnight and fixed for 15 min with 
4% PFA followed by PBS washes and permeabilization with 0.1% IGEPAL for 3 min at room 
temperature. Cells were blocked using 2% non-fat dry milk in PBS with 5% normal goat serum 
(Thermo Scientific, Wilmington, DE) for 1 h, followed by overnight incubation with rabbit α-
βcat 1:500 (Santa Cruz Biotechnologies, Dallas, TX) at 4°C. Slides were washed with PBS, 
incubated with goat α-rabbit Alexa Fluor 488 secondary antibody 1:800 (Jackson ImmunoLabs, 
West Grove, PA) for 1 h at room temperature, followed by nuclear counterstaining with DAPI 
and mounted using ProLong Gold Antifade Reagent (Life Technologies, Carlsbad, CA). 
Fluorescence microscopy was performed using an Optiphot-2 microscope (Nikon, Melville, NY) 
with an Olympus DP-70 camera and software (Olympus, Hauppauge, NY). 
 
ATCL7 cell treatments and electroporation 
For BIO experiments, cells were plated at a density of 2.5x105 cells per well in 6 well 
dishes and treated with 0.5 µM BIO for 12 h, followed by 100 nM ACTH stimulation for 6 h. 
For conditioned media experiments, cells were plated as above and treated with conditioned 
media for 18 h, followed by 100 nM ACTH stimulation for 6 h. For electroporation of ATCL7 
cells, an Amaxa Cell Line Nucleofector R Kit (Lonza, Walkersville, MD) was used following the 
manufacturer’s protocol. Briefly, 106 cells per transfection were trypsinized, resuspended in 
solution R with supplement 1 and mixed with 1 µg pcDNA 3.1 empty vector, 1 µg βcatS33Y 
and/or 1 µg dnTCF4E expression constructs. Cell mixtures were electroporated using program T-
20, plated in 4 wells of a 12 well dish and harvested 24 h later. 
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Cell fractionation and Immunoblotting  
For whole cell lysates, cells were harvested with RIPA buffer (Promega, Madison, WI) 
containing protease inhibitors (Sigma-Aldrich, St. Louis, MO) and PhosSTOP (Roche, 
Indianapolis, IN), rocked on ice for 20 min, scraped and sonicated briefly. For immunoblotting, 
1/10 of cell lysates (20ug) were subjected to SDS-PAGE and transferred onto PVDF membranes. 
Membranes were blocked in Odyssey Blocking Buffer (LI-COR, Lincoln, NE) 1:1 with PBS. 
Primary antibodies were diluted in TBS-T with 5% bovine serum albumin (BSA) (Roche, 
Indianapolis, IN) and incubated at 4°C overnight. Primary antibodies: rabbit α-Sf1 1:1000 
(custom), mouse α-Active βcat 1:500 (EMD Millipore, Billerica, MA), rabbit α-βcat 1:2000 
(Santa Cruz Biotechnologies Inc., Dallas, TX), mouse α-β-actin 1:5000, mouse α-FlagM2 
1:2000 (Sigma-Aldrich, St. Louis), rabbit α-myc 1:1000 (Bethyl Laboratories, Inc., 
Montgomery, TX), rabbit α-p-Erk1/2 (Thr202/Tyr204), rabbit α-Erk1/2, rabbit α-p-Creb 
(Ser133) and rabbit α-Creb were all used at 1:1000 (all obtained from Cell Signaling, Danvers, 
MA). Cell fractionation was achieved following the nuclear extraction protocol utilizing the 
Nuclear Extract Kit (Active Motif, Carlsbad, CA). For immunoblotting, equivalent proportions 
of each fraction were analyzed.  
 
RNA extraction and qRT-PCR 
Following specified treatments, cells were harvested using the RNeasy Mini Plus Kit 
(Qiagen, Valencia, CA). 1 ug of RNA was converted to cDNA utilizing the iScript Supermix 
Reverse Transcriptase Kit (Bio-Rad, Hercules, CA) following the manufacturer’s instructions. 
Quantitative real-time PCR was carried out using 10 ng of cDNA, 1 µM of specific primers (see 
Table 1) and Power SYBR Green reagent (Applied Biosystems, Foster City, CA) on an ABI 
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7300 thermocycler (Applied Biosystems, Foster City, CA). Gene expression was normalized to 
Rplp0 mRNA abundance and calculated using the ΔΔCt method. 
 
Chromatin immunoprecipitation 
ATCL7 cells were plated at a density of 6x106 cells per 150 mm dish per treatment for 12 
h. Cells were treated with 0.5 µM BIO or DMSO in low serum media for 12 h followed by 
stimulation with 100 nM ACTH for 6 h. Cells were cross-linked with 1% formaldehyde with 
rocking at room temperature for 10 min. The reaction was quenched by incubation with 0.125 M 
glycine with rocking at room temperature for 10 min. Cells were washed three times with ice-
cold PBS. Cell membranes were disrupted for 15 min at 4°C in nuclear extraction buffer 
containing 25 mM HEPES (pH 7.9); 5 mM KCl; 0.5 mM MgCl2; 1 mM DTT; 1% IGEPAL and 
protease inhibitors (Sigma-Aldrich, St. Louis, MO). Nuclei were isolated from cytoplasmic 
protein by centrifugation at 1,000xg for 5 min at 4°C. Nuclei were lysed in a buffer containing 
1% SDS; 10 mM EDTA; and 50 mM Tris-HCl (pH 8.1) for 10 min on ice. Lysates were 
sonicated at 100% amplitude, with 20 x 30 sec pulses using a Q500 sonicator with a 3” cup horn 
(Qsonica, Llc., Newtown, CT) to shear genomic DNA between 200 – 400bp. Sonicated lysates 
were cleared by centrifugation at 14,000xg for 10 min at 4°C and diluted 1:10 in a ChIP dilution 
buffer containing 0.01% SDS; 1.1% Triton X-100; 1.2 mM EDTA; 16.7 mM Tris-HCl (pH 8.1); 
and 167 mM NaCl. The diluted lysates were pre-cleared for 1 h at 4°C with Protein G 
Dynabeads (Life Technologies, Carlsbad, CA) prepared in ChIP dilution buffer with 200 µg/mL 
BSA and 200 µg/mL glycogen (both from Roche, Indianapolis, IN). 30 µg of chromatin per 
treatment was immunoprecipitated overnight at 4°C using 3 µg of Sf1 antibodies (custom) or 
rabbit IgG (Santa Cruz Biotechnologies, Inc., Dallas, TX). Immunoprecipitates were recovered 
for 1 h at 4°C with Protein G Dynabeads as prepared above. Precipitates were washed for 5 min 
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each with the following buffers: low salt buffer [0.1% SDS; 1% Triton X-100; 2 mM EDTA; 20 
mM Tris-HCl (pH 8.1); and 150 mM NaCl], high-salt buffer [0.1% SDS; 1% Triton X-100; 2 
mM EDTA; 20 mM Tris-HCl (pH 8.1); and 500 mM NaCl], LiCl buffer [(0.25 M LiCl; 1% 
IGEPAL; 1% deoxycholate; 1 mM EDTA; and 10 mM Tris-HCl, (pH 8.1)] and Tris-EDTA (pH 
8.0) buffer. Immunoprecipitates were eluted from Dynabeads with two 15 min incubations in 
elution buffer (1% SDS, 0.1 M NaHCO3). Cross-links were reversed by incubation at 65°C for 4 
h in the presence of 200 mM NaCl and 1 µg RNase A (Roche, Indianapolis, IN). Protein was 
digested by incubation for 30 min at 65°C in the presence of 10 mM EDTA, 40 mM Tris-HCl 
(pH 6.5) and 40 µg Proteinase K (Roche, Indianapolis, IN). DNA fragments were purified using 
a PCR Purification Kit (Qiagen, Valencia, CA) according to manufacturer’s instructions. Purified 
DNA fragments were analyzed by qPCR on an ABI 7300 thermocycler (Applied Biosystems, 
Foster City, CA) using Power SYBR Green reagent (Applied Biosystems, Foster City, CA). 
Primer pairs used for ChIP-qPCR are listed in Table 2. 
 
Corticosterone Measurement 
Experimental media from treated cells was collected at time of cell harvest and stored at -
20°C. The corticosterone content of the media samples was determined using a Mouse and Rat 
Corticosterone ELISA Kit (ALPCO Diagnostics, Salem, NH). Assays were conducted following 
the manufacturer’s instructions except standard curves were prepared in the cell culture medium. 
Protein concentration of corresponding cell lysates was assessed using a BCA Assay Kit (Bio-
Rad, Hercules, CA) according to manufacturer’s instructions. Corticosterone abundance was 
normalized to protein concentration and shown as fold change over Vehicle treated samples. 
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Adrenal Digestion and Cell Sorting 
10 adrenals per genotype per sort were minced and digested by incubation in DMEM:F12 
containing 0.1% collagenase (Roche, Indianapolis, IN), 0.01% DNaseI (Roche, Indianapolis, IN) 
for 1 h at 37°C. A single cell suspension was obtained following mechanical dispersion, filtration 
through a 40 µm nylon cell strainer, centrifugation at 320xg for 5 min followed by re-suspension 
in sterile PBS containing 10% cosmic calf serum and 10 µg/mL propidium iodide (Sigma-
Aldrich, St. Louis, MO). 10,000 – 50,000 viable GFP positive cells were isolated via FACS 
using a FACSAria III cell sorter (BD Biosciences, San Jose, CA). Cells were sorted directly into 
RLT buffer and RNA was harvested using an RNeasy Micro Kit (Qiagen, Valencia, CA).  
 
Microarray analysis 
We measured cell transcript abundances in two experiments using Affymetrix Mouse 
gene ST 1.1 strip arrays with 28944 probe-sets. In both cases RMA algorithms were used to 
measure log2 transformed transcript abundances.  In the in vivo experiment, RNA from 4 
independent sorts per genotype was used. cDNA were prepared according to the NuGen WT-
Pico V2 kit protocol from 5 ng total RNA (NuGEN, San Carlos, CA). Biotinylated single-
stranded cDNA were prepared from 3ug of cDNA using the Encore Biotin Module (NuGEN, 
San Carlos, CA). We used two-sample T-test to compare the two conditions in this data-set. One 
TCF/Lef:H2B-GFP sample was discarded for quality control reasons. For the in vitro 
experiment, RNA from 4 pairs of DMSO or 0.5 µM BIO treated ATCL7 cell preparations was 
used. Biotinylated cDNA samples were prepared using an Ambion WT Expression Kit from 250 
ng total RNA (Affymetrix, Santa Clara, CA). The data was modeled using paired T-tests for each 
probe-set. The array data and statistical analysis have been deposited in NCBI's Gene Expression 
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Omnibus (GEO) [11] and are accessible through GEO Series accession numbers GSE53971 and 
GSE53981.   
 
Plasmid Constructs and Mutagenesis 
For the Ccdc80-luciferase construct, -1957 to +814 surrounding the transcription start site 
of murine Ccdc80 was PCR amplified from genomic DNA using Phusion High-Fidelity DNA 
polymerase (New England BioLabs, Ipswich, MA) and the following primers: fwd, 5’-
AAAAGCTAGCAGCTGGTTGTGGGATGGATG-3’, adding an Nhe I site; rev, 5’-
TGTAAGATCTACTTGGGGACGCAGAGGGGGTATAAT-3’, adding a Bgl II site. The PCR 
product was subcloned into the pGL3-Basic vector (Promega, Madison, WI) using the 
engineered Nhe I and Bgl II sites. Core elements of TCF binding sites were mutated from 
AA(A/G)A to CGCT by site-directed mutagenesis using Calbiochem KOD Hot Start Polymerase 
reagents (EMD Millipore, Billerica, MA) according to the manufacturer’s instructions. Primers 
sets for site directed mutagenesis are listed in Table 3. 
 
Luciferase Assays  
293T cells were plated at a density of 2.5x104 cells per well into 24-well plates and 
incubated for 24 h. For BIO treatment experiments: cells were transiently transfected with 25 ng 
empty vector pcDNA3.1 construct or 25 ng Sf1 expression construct, 100 ng Star-luciferase 
reporter construct and 30 ng of Renilla-luciferase reporter construct using Fugene HD (Roche, 
Indianapolis, IN). 24 h after transfection, cells were treated with 2 µM BIO or DMSO for 24 h 
and then harvested. For βcatS33Y experiments: cells were transiently transfected with 25 or 125 
ng empty vector pcDNA3.1 construct and/or 25ng Sf1 expression construct and/or 100ng 
βcatS33Y expression construct with 100 ng Star-luciferase reporter construct and 30 ng of 
Renilla-luciferase reporter construct using Fugene HD (Roche, Indianapolis, IN). Cells were 
  43 
harvested 48 h post transfection. For Ccdc80-luciferase experiments: cells were transiently 
transfected with 100 ng specific Ccdc80-luciferase reporter constructs and 30 ng Renilla-
luciferase reporter construct using Fugene HD (Roche, Indianapolis, IN). 24 h later cells were 
treated with 2 µM BIO or DMSO for 24 h and then harvested. Cells were lysed with Passive 
Lysis Buffer and luciferase assays were performed using the Dual-Luciferase Reporter Assay 
System (Promega, Madison, WI) according to manufacturer’s instructions on a Veritas 
Microplate Luminometer (Turner BioSystems, Sunnyvale, CA).  
 
Preparation of conditioned media 
293T cells were plated at a density of 2x106 cells per 100 mm dish and transfected with 
19 µg Ccdc80-myc or 19 µg empty vector pcDNA 3.1 construct using Fugene HD (Roche, 
Indianapolis, IN) in low serum media.  24 h later, conditioned media were collected and 
centrifuged at 1,000xg for 5 min to pellet floating cells and debris, sterile-filtered through 0.22 
µm filters, aliquoted and frozen at -80°C. Thawed conditioned media were mixed 1:1 with fresh 
ATCL7 low serum growth media just prior to use in experiments.  
 
Statistical analysis 
Unless otherwise noted, data in figures is from repeated experiments with 1 sample per 
condition per experiment, with the means for each condition and the standard deviations for each 
condition with main experiment effects removed being shown.  The analyses are from two-way 
analysis of variance procedures on log-transformed data with terms for each condition and each 
experiment, which in the simplest case of two conditions are paired T-tests.  Commonly, 
pairwise contrasts comparing pairs of conditions were tested, but occasional tests of interactions 
between two treatments required comparing the difference of differences in pairs of conditions. 
Tests with p-values less than 0.05 were considered significant. 
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RESULTS  
 
Wnt-responsive cells in the adult adrenal cortex are a heterogeneous population in vivo 
The subcapsular adrenal cortex is the location of both 1) cells that are activated in 
response to signals from canonical Wnt ligands [3] and 2) cells that produce the ligand Shh [1]. 
The peripheral cortex is also the primary location where adrenocortical cells proliferate [12]. 
Because Shh-producing cells primarily serve as relatively undifferentiated progenitor cells for 
the steroidogenic cortex [1] and Wnt signaling participates in the maintenance of the 
adrenocortical progenitor pool [3], we sought to delineate any shared identity of Wnt-responsive 
and Shh-producing cells and determine the mechanisms by which Wnt/βcat-signaling contributes 
to homeostasis of the adult adrenal cortex. We hypothesized that Wnt-responsive cells would be 
identical to the Shh-producing progenitors. Additionally, given a role for βcat in the regulation of 
proliferation during adrenocortical development [3], we speculated that proliferating 
adrenocortical cells in the adult gland would be Wnt-responsive cells. Therefore, to determine 
whether Wnt-responsive cells colocalize with markers of adrenocortical progenitors and/or 
proliferating cells, we crossed the Tcf/Lef:H2B-GFP reporter mice with ShhLacZ reporter mice 
and performed immunofluorescence on adult adrenal sections. We observed that while many 
GFP+ (Wnt-responsive) cells do not co-express LacZ, most LacZ+ (Shh-producing) progenitor 
cells costain as GFP+ (Wnt-responsive) cells (Figure 2.1A). Surprisingly, less than 10% of GFP+ 
(Wnt-responsive cells) colocalize with dividing, PCNA+ cells (Figure 2.1C). This fraction of the 
GFP+ population constitute less than 30% of the proliferating adrenocortical cells, suggesting 
that Wnt signaling does not play a primary (cell autonomous) role in regulating adrenocortical 
proliferation (Figure 2.1A,C). Moreover, less than 1% of LacZ+ (Shh+) cells colocalize with 
PCNA+ cells, indicating Shh+ progenitor cells are relatively quiescent (Figure 2.1A,C). Similar 
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results were obtained utilizing BrdU to mark proliferating cells in Tcf/Lef:H2B-GFP; ShhLacZ 
mice (Figure 2.1B). These data suggest that a subset of Wnt-responsive cells are adrenocortical 
Shh-producing progenitor cells, however, the proliferation of adrenocortical cells during normal 
maintenance of the adult gland appears to be independent of a direct effect of Wnt signaling.  
 
 In addition to progenitor cells, the peripheral subcapsular region contains differentiated, 
steroidogenic cells of the zG that express Cyp11b2, the terminal enzyme in aldosterone 
production. Because a substantial proportion of GFP+ (Wnt-responsive) cells do not co-stain 
with LacZ (indicative of the undifferentiated Shh+ cells), we asked whether Wnt-responsive cells 
colocalize with Cyp11b2+ cells using immunofluorescence. We found that most Cyp11b2+ cells 
colocalized with a subset of GFP+ cells (Figure 2.1D). In contrast, differentiated Cyp11b1+ cells 
of the zF were not GFP+ cells (Figure 2.1E). Collectively, these data indicate that adrenocortical 
Wnt-responsive cells constitute a heterogeneous population, containing Shh+ progenitor cells 
and differentiated Cyp11b2+ cells of the zG.  
 
Adrenocortical cell model of βcat signaling 
The mutually exclusive expression of GFP (Wnt-responsive cell) and Cyp11b1 (zF cell) 
suggest that Wnt signaling may serve to repress the differentiation of progenitor cells into 
Cyp11b1+ expressing cells of the zF. We therefore examined in vitro the effects of Wnt/βcat 
signaling on steroidogenesis in a Cyp11b1-expressing zF cell line. The Wnt gain-of-function 
mutations present in most adrenocortical cell lines (i.e. H295A/R, HAC15) necessitate genetic or 
pharmacologic loss-of-function experiments that are fraught with an inability to achieve 
adequate suppression of Wnt signaling, making interpretation of results extremely difficult. 
Moreover, the reduced cell viability induced by even the partial reduction of βcat expression in 
the H295R cell line is consistent with oncogene addiction and hampers data interpretation [13]. 
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We therefore opted to use the ATCL7 adrenocortical cell line derived from adrenocortical 
tumors of mice that harbor SV40 large T antigen driven by an Sf1-responsive promoter [14]. 
Importantly, these cells do not have any gain of function mutations in βcat and hence the Wnt 
signaling pathway is not basally active but can be stimulated pharmacologically, reflecting more 
accurately the physiological inducibility of this signaling pathway (Figure 2.2A). Treatment of 
ATCL7 cells with the GSK3β inhibitor BIO (6-bromoindirubin-3-oxime) induces βcat 
stabilization and nuclear translocation (Figure 2.2A,B) that results in transcriptional engagement 
of the canonical Wnt-responsive gene Axin2 (Figure 2.2C), indicating that ATCL7 cells serve as 
an excellent model of adrenocortical Wnt/βcat-signaling in vitro. 
 
Induction of βcat activity suppresses zF steroidogenesis in vitro 
Given that Wnt-responsive cells in the adrenal cortex constitute both progenitor cells and 
differentiated cells of the mineralocorticoid-producing zG that express Cyp11b2 (and specifically 
not the differentiated cells of the glucocorticoid-producing zF that express Cyp11b1), we 
examined whether induction of βcat activity influences the steroidogenic function of ATCL7 
adrenocortical cells. ATCL7 cells do not express Cyp11b2 and therefore do not produce 
aldosterone. However, they do express the full complement of enzymes involved in production 
of corticosterone, consistent with a zF cell phenotype.  Upon induction of βcat activity with BIO 
treatment, basal and ACTH-induced corticosterone release was significantly reduced (Figure 
2.3A). We therefore assessed if reduction of corticosterone secretion was due to altered 
expression of steroidogenic enzymes. Treatment of ATCL7 cells with BIO resulted in down-
regulation of the basal and ACTH-induced expression of the steroidogenic genes Cyp11a1, Star 
and most importantly Cyp11b1 as measured by qRT-PCR (Figure 2.3C-E). Additional reduction 
in ACTH receptor (Mc2r) gene expression and concomitant downstream signaling through 
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MAPK/ERK and PKA pathways was also reduced following BIO treatment, as reflected in 
reduced levels of pCreb and pErk1/2 under basal and ACTH-stimulated conditions (Figure 
2.3F,G).  
 
BIO-induced reduction of steroidogenesis is due to effects on Sf1 
The above data suggest that the effects of Wnt-activation on steroidogenesis may be 
mediated by primary effects on Mc2r expression and subsequent signaling effects on 
steroidogenic enzyme expression and corticosterone secretion. However, since Mc2r and the 
majority of steroidogenic enzymes are direct Sf1 target genes, we investigated whether the 
suppression of steroidogenesis by BIO could be in part mediated by direct effects on Sf1 
expression or Sf1 transcriptional activity.  Stimulation of βcat in ATCL7 cells with BIO resulted 
in a marked decrease in Sf1 expression as measured by qRT-PCR and immunoblotting (Figure 
2.4A,B). We performed chromatin immunoprecipitation experiments with antibodies directed 
against Sf1 to examine whether reduction in Sf1 expression results in less Sf1 occupancy at 
target promoters. Sf1 was markedly reduced at the promoters of Star, Cyp11a1 and Mc2r under 
basal and ACTH-stimulated conditions (Figure 2.4C-E). We next assessed whether BIO 
treatment decreased Sf1 transcriptional activity independent of changes in Sf1 levels.  
Stimulation of the heterologous 293T cell line with BIO resulted in a reduction of Star-luciferase 
activity in the presence of equivalent amounts of Sf1 (Figure 2.4F). These results were 
recapitulated using βcatS33Y, a mutant βcat that is constitutively active [15] (Figure 2.4G), 
indicative of a βcat-dependent inhibitory effect of BIO on Sf1-mediated transcription. These 
results demonstrate that, in addition to modulating Sf1 levels, induction of βcat activity interferes 
with the ability of Sf1 to transactivate steroidogenic promoters. 
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Gene expression profiling of Wnt-responsive cells in vitro and in vivo reveals novel genes 
regulated by Wnt/βcat signaling in adrenocortical cells 
It is plausible that βcat additionally activates (as opposed to inhibits) genes that influence 
steroidogenesis through Sf1-independent mechanisms. Therefore, in order to determine genes 
induced by Wnt/βcat signaling in vitro, 4 paired samples of BIO or Vehicle treated ATCL7 cells 
were subjected to gene expression profiling with Affymetrix Mouse gene ST 1.1 strip arrays. We 
sought to identify genes induced by βcat stimulation in vitro that were also expressed in Wnt-
responsive adrenocortical cells in vivo. To determine the panel of genes more highly expressed in 
the Wnt-responsive population versus genes expressed throughout the adrenal cortex, we 
employed two different lines of transgenic reporter mice: Tcf/Lef:H2B-GFP mice express GFP 
in Wnt-responsive cells, while Sf1:eGFP mice express GFP in all adrenocortical cells. GFP+ 
adrenocortical cells were obtained from 6 week old male Tcf/Lef:H2B-GFP mice and Sf1:eGFP 
mice independently via FACS. RNA samples extracted from 4 independent sorts of 10 adrenals 
per genotype were assessed using Affymetrix Mouse gene ST 1.1 strip arrays. Genes highly 
expressed in the Tcf/Lef:H2B-GFP population compared to the Sf1:eGFP population were 
intersected with genes up-regulated in ATCL7 cells by BIO treatment versus Vehicle treatment 
(Figure 2.5). While known Wnt target genes present in other organ systems were captured at the 
intersection, such as Tnfrsf19 and Nkd1 [16, 17], we focused our efforts on Ccdc80, the gene 
with the largest fold-increase upon BIO treatment that was also expressed in Wnt-responsive 
cells in vivo. 
  
Ccdc80 is a βcat-regulated gene in adrenocortical cells 
Given that Ccdc80 was enriched in both data sets, we hypothesized that Ccdc80 was a 
bona fide direct target gene of Wnt/βcat signaling. Treatment of ATCL7 cells with BIO induced 
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Ccdc80 expression, consistent with our gene expression profiling (Figure 2.6A). To determine 
whether the induction of Ccdc80 was dependent on a transcriptionally competent βcat/TCF 
complex, we electroporated ATCL7 cells with βcatS33Y alone or in combination with a 
dominant-negative TCF (dnTCF4E). As transfection of ATCL7 cells is very inefficient, we 
compared changes in Ccdc80 expression with induction of Axin2. Forced expression of 
βcatS33Y in ATCL7 cells increased Ccdc80 expression, commensurate with an increase in 
Axin2 levels (Figure 2.6B). This increase was abrogated in the presence of dnTCF4E, suggesting 
regulation of Ccdc80 expression by a βcat/TCF complex. Sequence analysis of the promoter 
region of Ccdc80 with MatInspector [18] revealed four potential TCF/LEF binding sites within a 
2 kb region encompassing the transcription start site (Figure 2.6C). We constructed a series of 
luciferase reporters containing this region of the Ccdc80 promoter with each TCF site 
individually mutated. As with endogenous Ccdc80 expression, treatment of 293T cells with BIO 
induced activity of Ccdc80-luciferase (Figure 2.6D). While mutation of putative TCF site 1 did 
not suppress the induction of Ccdc80-luciferase activity, individual mutation of TCF sites 2, 3 or 
4 abolished BIO-induced luciferase activity of these constructs (Figure 2.6D). These data 
indicate that Ccdc80 is a direct βcat/TCF-regulated gene and that each of the three putative TCF 
sites is essential for promoter-proximal Wnt-mediated transcriptional activation of Ccdc80.  
 
Ccdc80 suppresses steroidogenesis in vitro 
We identified a novel βcat regulated gene in adrenocortical cells, Ccdc80. While little is 
known about the function of Ccdc80, it has been recently shown to be a secreted protein 
implicated in pre-adipocyte differentiation and extracellular matrix biology, including the 
potentiation of growth factor / growth factor receptor interaction [19, 20]. Because βcat signaling 
activates Ccdc80 expression and suppresses Sf1-mediated zF cell steroidogenesis, we sought to 
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determine whether Ccdc80 also contributed to Wnt-mediated steroidogenic inhibition in 
adrenocortical cells.  We first generated Ccdc80-conditioned media (CM) to confirm its identity 
as a secreted protein and to allow for an evaluation of its role as an extracellular regulator of 
adrenocortical steroidogenesis. Immunoblot analysis revealed that Ccdc80-myc expressed in 
293T cells is present in both cell lysates and collected media. Ccdc80-myc migrates on SDS-
PAGE at ~110 kDa, with multiple higher molecular weight bands likely due to its glycosylation 
(Figure 2.7A). Treatment of ATCL7 cells with Ccdc80-containing CM resulted in a reduction in 
basal and ACTH-induced corticosterone secretion in comparison to treatment of cells with CM 
from 293T cells transfected with an empty vector (Figure 2.7B). As in our previous experiments 
with βcat stimulation, treatment with Ccdc80 CM resulted in a significant decrease in expression 
of Star, Cyp11a1 and Cyp11b1 (Figure 2.7C-E). In contrast, treatment of ATCL7 cells with 
Ccdc80 CM did not affect expression of Mc2r or Sf1 (Figure 2.7F,G,I). Given that treatment of 
ATCL7 cells with Ccdc80 CM partially phenocopies the induction of βcat in these cells, we 
assessed βcat levels and transcriptional activity. Treatment with Ccdc80 CM does not induce 
βcat stability or Axin2 expression (Figure 2.7H,I). Together with the findings that pErk and 
pCreb levels are unchanged in the presence of Ccdc80 CM (Figure 2.7I), these data indicate that 
Ccdc80 is likely suppressing steroidogenesis through mechanisms distinct from signaling events 
initiated through Wnt or Mc2r signaling. 
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DISCUSSION 
Wnt signaling plays diverse, tissue-specific roles that include progenitor cell 
maintenance, self-renewal, proliferation, cell survival, cell fate commitment and differentiation 
in multiple organ systems. The mechanisms by which Wnt signaling participates in such a wide 
variety of processes is complicated by the multiplicity of ligand/receptor pairings and the 
presence of a host of secreted repressive coregulators. The mammalian Wnt pathway has 19 
different ligands and 10 different Fzd receptors; each Wnt can bind every receptor (with varying 
affinity) and has the capacity, depending on the cellular context, to elicit canonical (through 
βcat) or noncanonical Wnt pathway activation [21]. Concentration gradients of competing 
secreted Wnt ligands and Wnt inhibitors can activate and potentiate distinct genetic programs 
dependent upon the relative abundance of stabilized βcat [22]. The rules that dictate how these 
various components are temporally and spatially integrated with other intersecting signaling 
pathways (FGFs, IGF) to regulate physiologic Wnt responses in the mammalian adrenal cortex 
are relatively unknown.     
 
The current study aimed to characterize the cells in the mouse adrenal cortex that 
participate in Wnt-mediated organ homeostasis.  In this report, we demonstrate that the Wnt-
responsive cells in the peripheral cortex of the adrenal gland are indeed a heterogeneous 
population containing both undifferentiated Shh-producing progenitor cells and differentiated 
mineralocorticoid-producing cells of the zG. Surprisingly, the Wnt-responsive cells constitute 
only a small fraction of the proliferating adrenocortical cells in the adult mouse under normal 
conditions. These results were unanticipated given the increased adrenocortical cell proliferation 
observed in the adrenals of mice with genetic gain of Wnt pathway function, versus the 
decreased proliferation present in mice with loss of Wnt pathway activation [3, 23-25]. It has 
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remained unclear whether the Wnt-responsive cells or perhaps their descendants are the bona 
fide proliferating cells in these mutant adrenal cortices.  It is plausible that during simple 
homeostatic organ maintenance, Wnt signaling contributes indirectly to adrenocortical 
proliferation through up-regulation of paracrine factors that promote cell proliferation in a non-
cell-autonomous fashion, and/or, that during organ re-growth following injury repair (as opposed 
to organ maintenance), Wnt-responsive cells contribute more directly to the proliferating pool of 
adult adrenocortical cells. 
 
Previous studies have highlighted the role of both βcat and the βcat target genes Dax1 
and inhibin-α (Inhα) in the maintenance of the undifferentiated state of adrenocortical 
progenitors (Dax1) and the fidelity of an adrenal versus a gonadal fate of these progenitors 
(Inhα) [3, 6, 26]. Additionally, adrenals from mice with adrenocortical-specific knockout of 
APC, a component of the βcat destruction complex, exhibit cell accumulation at the cortical-
medullary boundary that express Sf1, stabilized βcat and Dax1, but not markers of differentiated 
zG or zF cells [23]. Collectively, these findings demonstrate that βcat maintains the 
undifferentiated state of adrenocortical progenitors through suppression of steroidogenesis and 
restriction of differentiation to an adrenal fate.  However, the interpretation of these data are 
challenging in light of a recent study supporting a stimulatory role of adrenocortical Wnt 
signaling in zG differentiation through indirect regulation of aldosterone synthesis [7]. DeltaCat 
mice engineered to express a genetically modified, constitutively active βcat, partially 
phenocopy mice with adrenocortical-specific knockout of APC, with aberrant cell accumulation 
at the cortical-medullary boundary. These cells express Sf1 and stabilized βcat, however a subset 
displays ectopic expression of Cyp11b2 resulting in overt hyperaldosteronism [24].  Supporting 
such a role of Wnt signaling in aldosterone production in the zG is the loss of secreted Wnt 
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inhibitors recently observed in aldosterone-producing adenomas (APA) [7]. In our current study, 
we now report that stimulation of βcat reduces fasciculata steroidogenic enzyme expression and 
corticosterone secretion. Our molecular data indicates that βcat signaling may actively repress zF 
cell differentiation. This is supported by our observation that Wnt-responsive cells do not overlap 
with Cyp11b1+ cells in vivo. Additionally, deltaCat adrenals that have stabilized βcat throughout 
the adrenal cortex have fewer zF cells and lower Cyp11b1 expression compared to wildtype 
animals [24]. The combined data support an emerging model whereby Wnt signaling in the 
adrenal cortex serves to inhibit a fasciculata fate and facilitate a glomerulosa fate.   
 
An interesting aspect of our study is that the repressive effect of βcat signaling on 
fasciculata steroidogenesis is partially mediated through effects on Sf1 expression and activity. 
Here we find that stimulation of βcat activity results in down-regulation of Sf1 expression and 
decreased occupancy of Sf1 from steroidogenic promoters. While transcriptional regulation of 
Sf1 expression in the adult adrenal is not well characterized, it is plausible that βcat can directly 
repress the Sf1 gene through conserved Tcf/Lef binding sites upstream of its transcription start 
site (Zubair and Hammer, unpublished observation), or that βcat can activate genes that 
negatively regulate Sf1 expression. Nonetheless, independent of changes in Sf1 expression, we 
find that in a heterologous cell line, βcat reduces the ability of Sf1 to transactivate steroidogenic 
promoters. Additionally, in a fasciculata cell line, stimulation of βcat decreases expression of a 
number of steroidogenic enzymes including Cyp11b1 that is responsible for glucocorticoid 
production and defines the differentiated state of these cells.  Because Sf1 has been shown to 
actually repress the expression of Cyp11b2 that is responsible for mineralocorticoid production 
[27], it is plausible that the observed Wnt-mediated facilitation of zG fate [7, 24] involves in part 
the release of Sf1-mediated repression of Cyp11b2.  Similarly, in the developing gonad, the roles 
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of Wnt signaling as an activator versus repressor of Sf1 activity are temporally and spatially 
distinct. In the ovary, βcat blocks Sf1-mediated testis differentiation by removing Sf1 from the 
Tesco enhancer of Sox9 [28]. Given that Sf1 and βcat synergistically co-activate a subset of 
genes involved in progenitor cell biology, including Dax1 and Inhα, a model emerges whereby 
Wnt pathway activation potentially titrates Sf1 away from the zF promoters of pro-
differentiation/steroidogenic genes to co-regulate genes involved in progenitor cell biology 
(Dax1, Inhα) and subsequent activation of a zG fate.  
 
In this report we also unveil a unique Sf1-independent mechanism of Wnt-mediated 
suppression of zF steroidogenesis. In search of Wnt-activated targeted genes, Ccdc80 emerged as 
a novel βcat-regulated gene that encodes a secreted protein in the peripheral adrenal cortex. 
Ccdc80 was originally cloned as Urb, a gene up-regulated in brown adipose tissue in bombesin-
receptor-3 knockout mice [29] and subsequently shown to be down-regulated in adipose tissue in 
obese mouse models versus wild-type mice [30]. The exact role for Ccdc80 in adipose 
differentiation is unclear as both overexpression and knockdown of Ccdc80 resulted in 
suppression of pre-adipocyte differentiation [19]. In human cancer cell lines Ccdc80, also known 
as Dro1 (Down-regulated-by-oncogenes-1), was demonstrated to have reduced expression 
compared to primary tissues and its expression was down-regulated by various oncogenic insults 
in immortalized cells [31]. Re-expression of Ccdc80/Dro1 reduced anchorage-independent cell 
growth and sensitized several cancer cell lines to induced apoptosis in numerous studies [31-33]; 
however, how Ccdc80 elicits these effects is unclear. Several studies on the chicken ortholog of 
Ccdc80, Equarin, have revealed that it is critical for lens differentiation through two functional 
outputs of heparan sulfate proteoglycan binding: promoting cell adhesion and facilitating FGF 
signaling [20, 34]. Little is known about the role of the extracellular matrix and cell adhesion in 
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steroidogenesis or the adrenal progenitor niche. A role for FGF signaling in the adrenal cortex 
has only recently been appreciated. Guasti et al. found expression of FGF ligands and receptors 
in both the adrenal capsule and the adrenal cortex. Global Fgfr2IIIb knockout adrenals exhibit 
adrenal hypoplasia by e15.5 in part due to reduced proliferation in both the adrenal capsule and 
cortex, reflecting a role for FGF signaling in adrenal development [35]. Any potential roles of 
the extracellular matrix and signaling pathways in Ccdc80 regulation of adrenal homeostatic 
maintenance will be an important area of future research, as will potential roles of Ccdc80 on zG 
function. 
  
In summary, we propose a model in which the fate of adrenocortical progenitor cells 
(maintenance vs. differentiation) is regulated by temporal and spatial integration of paracrine and 
endocrine stimuli (Figure 2.8). Our data, in combination with other studies, suggests that Wnt 
signaling is primarily maintaining the undifferentiated state of adrenal progenitors, yet ‘priming’ 
them to become zG cells upon endocrine differentiation signals (AngII/ACTH). In this model, 
paracrine signals (Wnt) would keep progenitor cells undifferentiated (through expression of 
Dax1, [6]) yet primed to differentiate directly to a zG cell (through expression of the Angiotensin 
receptor (At1r) and Nr4a1/2 genes, [7]), while zF differentiation is actively repressed (by effects 
on Sf1 and through Ccdc80, as shown in this study). In times of greater physiological need for 
increased steroid production, endocrine signals could override paracrine inputs and promote 
differentiation and steroidogenesis. Evidence for such phenomena are supported in this study, 
where ACTH stimulation reduces the induction of βcat signaling, reflected in a decrease of 
Axin2 levels induced by BIO (Figure 2.3), and in other studies, where AII stimulation of H295R 
cells decreases the expression of βcat target genes Axin2 and Lef1 [7]. How paracrine and 
endocrine signals are integrated or override one another to dictate the fate of adrenal progenitors 
  56 
remains unclear, but likely involves thresholds and temporal regulation. Freedman et al. 
demonstrated that, under normal conditions, all fasciculata cells are derived from glomerulosa 
cells [2]. Stem and progenitor cells in multiple organ systems engage differently depending on 
pathological perturbation or injury repair vs. normal homeostatic maintenance [36, 37]. Indeed, 
ACTH clears transcriptional activators from the Dax1 promoter, thereby shutting off this gene 
[38]. It remains possible that under great physiological need to replenish zF cells, such as 
regrowth following dexamethasone-induced atrophy of the zF, a portion of progenitor cells could 
differentiate directly into zF cells without a zG intermediate. Future studies of dynamic models 
of injury repair will be necessary to further define the diverse cellular populations engaged in the 
complex process of adrenal homeostasis. 
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FIGURES 
 
 
 
 
 
Figure 2.1: The Wnt-responsive population is heterogeneous in vivo.  
 
Adrenal glands from 6 week old male Tcf/Lef:H2B-GFP, ShhLacZ mice were evaluated on 
paraffin sections. (A) Representative coimmunofluorescence image for LacZ, GFP, PCNA and 
nuclear counterstain DAPI. Inset at the right is an overlay without DAPI. (B) 
Coimmunofluorescence images for BrdU, GFP, LacZ staining. Mice were harvested 2 h after one 
single BrdU injection. Inset at the bottom is an overlay without DAPI.  (C) Quantification of data 
from (A) from 3 sections each of n=7 animals, error bars represent SEM. Diagram at the right 
represents the relative size and overlap of each population graphically. (D) 
Coimmunofluorescence images of Cy11b2 and GFP. (E) Coimmunofluorescence images of 
Cyp11b1 and GFP. Scale bars: 100 µm. 
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Figure 2.2: Adrenocortical cell model of βcat activity.  
 
ATCL7 cells were treated with 0.5 µM BIO or Vehicle (DMSO) in low serum media for 24 h. 
(A) Subcellular localization of βcat was assessed using immunocytochemistry with βcat 
antibodies. (B) ATCL7 cells were separated into nuclear and cytoplasmic fractions. Fractionation 
of βcat was determined by SDS-PAGE and immunoblotting. Nuclear Lamin A/C and 
cytoplasmic β-tubulin serve as loading and fractionation controls. (C) qRT-PCR assessing Axin2 
expression 8 and 24 h post treatment. Values represent the mean±SD, where Vehicle treated cells 
were normalized to 1 (n = 4, ** p < 0.005) *** p <0.0005).  
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Figure 2.3: Stimulation of βcat activity inhibits basal and ACTH-induced zF 
steroidogenesis in vitro.  
 
ATCL7 cells were pretreated with 0.5 µM BIO or Vehicle for 12 h in low serum media followed 
by 100 nM ACTH stimulation for 6 h and harvested. (A) Harvested media were subjected to 
ELISA to measure corticosterone release (n = 4). Experimental values were calculated as ng 
corticosterone/mg of protein and normalized to double Vehicle treated cells. (B-F) qRT-PCR 
assessment of changes in expression of Axin2 (B), Cyp11b1 (C), Star (D), Cyp11a1 (E) and 
Mc2r (F). Values represent the mean±SD, where Vehicle treated cells were normalized to 1 (n = 
4, **** p<0.00005, *** p<0.0005, ** p<0.005, *p<0.05, n.s. = not significant). (G) Protein level 
changes were assessed by immunoblotting for p-Erk1/2 (Thr202/Tyr204), total Erk1/2, p-Creb 
(Ser133), total Creb and β-actin (n = 3, representative data shown). 
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Figure 2.4: βcat activity affects Sf1 levels, promoter occupancy and transcriptional activity 
 
ATCL7 cells were pretreated with 0.5 µM BIO or Vehicle for 12 h in low serum media followed 
by 100 nM ACTH stimulation for 6 h and harvested. (A) Changes in Sf1 mRNA levels were 
assessed by qRT-PCR. Values represent the mean±SD, where Vehicle treated cells were 
normalized to 1 (n = 4, ** p<0.005, * p<0.05). (B) Sf1 protein levels were assessed by 
immunoblot (n = 4, representative data shown). Quantification of changes in Sf1 protein level is 
normalized to β-actin levels. (C-E) Changes in Sf1 DNA occupancy was measured by ChIP 
assays using Sf1 antisera. Immunoprecipitates were analyzed by qPCR using primers for the 
proximal promoters of Star (C), Cyp11a1 (D) and Mc2r (E). Pre-immune IgG antisera were used 
as a negative control. Experimental values are normalized to 2% input (n = 4, * p<0.05). (F) 
293T cells were transfected with Star-luciferase reporter construct, Renilla-luciferase internal 
control construct and empty vector or Sf1 expression construct for 24 h. Transfected cells were 
treated with 2 µM BIO or Vehicle for 24 h before passive lysis. Luciferase activity was measured 
and normalized to Renilla luciferase for transfection efficiency. Values represent the mean±SD 
(n = 4,  *** p<0.0005, ** p<0.005, *p<0.05, n.s. = not significant). Protein levels of Active-βcat 
(ABC), Sf1 and β-actin were measured by immunoblotting (lower panels, n = 4, representative 
data shown). (G) 293T cells were transfected with Star-luciferase reporter construct, Renilla-
luciferase internal control construct and empty vector, Sf1 or flag-tagged βcatS33Y alone or in 
combination for 48 h before passive lysis. Luciferase activity was measured and normalized to 
Renilla luciferase for transfection efficiency. Values represent the mean±SD (n = 4,  *** 
p<0.0005, ** p<0.005, *p<0.05). Protein levels of Flag-βcatS33Y, Sf1 and β-actin were 
measured by immunoblotting (lower panels, n = 4, representative data shown). 
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Figure 2.5: Assessment of the gene expression profile of Wnt-responsive cells in vitro and in 
vivo.  
 
Schematic representation of microarray workflow. (Left, Top) GFP+ adrenocortical cells were 
obtained from 6 week old male TCF/Lef:H2B-GFP mice and Sf1:eGFP mice independently via 
FACS. RNA was extracted from 4 independent sorts per genotype. Using two-sample T-tests we 
asked that probe-sets give p<.05 and average fold-changes of at least 1.5, which selected 636 
increased and 907 decreased probe-sets in Tcf/Lef:H2B-GFP+ cells, 15% of which were 
expected to be false positives bases on analysis of data-sets where the sample labels were 
randomly permuted (Right, Top) ATCL7 cells were treated for 24 h with 0.5 µM BIO or Vehicle 
in low serum media prior to harvesting and RNA extraction. 4 pairs of treated cells were used for 
expression profiling. We asked that paired T-tests give p<.05 and average fold-changes or at 
least 1.5, which selected 499 up and 746 down probe-sets in BIO treated cells, of which we 
expect 0.1% to be false positives based on analysis of data-sets where sample labels were 
permuted within the pairs of samples.  The intersection of up probe-sets in the two experiments 
was 25 probe-sets, representing the 24 distinct genes shown in the heatmap at bottom 
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Figure 2.6: Ccdc80 is a novel βcat regulated gene in adrenocortical cells 
 
ATCL7 cells were treated with 0.5 µM BIO or Vehicle for 18 h in low serum media and 
harvested. (A) Changes in Ccdc80 expression were assessed by qRT-PCR. Values represent the 
mean±SD, where Vehicle treated cells were normalized to 1 (n = 4, ** p<0.005). (B) ATCL7 
cells were electroporated with empty vector, βcatS33Y or dnTCF4E alone or in combination. 48 
h post transfection, cells were harvested and changes in Axin2 expression (left) and Ccdc80 
expression (right) were measured by qRT-PCR. Values represent the mean±SD, where Vehicle 
treated cells were normalized to 1 (n = 4, **** p<0.00005, *** p<0.0005, ** p<0.005, n.s. = not 
significant). (C) Diagram of Ccdc80-luciferase reporter construct. -1957 to +814 upstream of the 
transcription start site of Ccdc80 was cloned into pGL3b luciferase reporter plasmid. Four 
putative Tcf/Lef binding sites identified using Genomatix MatInspector are labeled #1-4. (D) 
293T cells were transfected with wildtype Ccdc80-luciferase construct or constructs with each 
individual Tcf binding site mutated (1-4) and Renilla luciferase internal control construct for 24 
h. Cells were treated with 2 µM BIO or Vehicle for 24 hr before passive lysis. Luciferase activity 
was measured and normalized to Renilla luciferase for transfection efficiency. Values represent 
the mean±SD, where WT, Vehicle treated cells were normalized to 1 (n = 4,  *** p<0.0005, ** 
p<0.005, *p<0.05, n.s. = not significant). 
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Figure 2.7: Ccdc80 suppresses basal and ACTH-induced zF steroidogenesis in vitro 
 
(A) 293T cells were transfected with Ccdc80-myc or empty vector for 24 h and harvested. Media 
was collected at time of harvest. Concentrated conditioned media and cell lysates were subjected 
to immunoblotting for Myc. (B) ATCL7 cells were treated with Mock or Ccdc80-conditioned 
media derived as in (A) for 18 h followed by 100 nM ACTH stimulation for 6 h and harvested. 
Media collected at harvest were subjected to ELISA to measure corticosterone release (n = 4). 
Experimental values were calculated as ng corticosterone/mg of protein and normalized to 
untreated cells. (C-H) qRT-PCR assessment of changes in expression of Star (C), Cyp11a1 (D), 
Cyp11b1 (E), Mc2r (F), Sf1 (G) and Axin2 (H) (n = 4, **** p<0.00005, *** p<0.0005, ** 
p<0.005, *p<0.05, n.s. = not significant). (I) Protein level changes were measured by 
immunoblotting for p-Erk1/2 (Thr202, Tyr204), total Erk1/2, p-Creb (Ser133), total Creb, Sf1, 
βcat and β-actin (n = 3, representative data shown). 
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Figure 2.8: Integration of Wnt and endocrine signals dictate adrenocortical cell fate. 
 
AngII and ACTH promote steroidogenesis in the zG and zF respectively, defining the 
differentiated state of the two adrenocortical cell types. Wnt signals stimulate βcat that inhibits 
the transcription of steroidogenic genes and transcriptionally activates Ccdc80, a secreted protein 
that in turn also inhibits steroidogenic gene expression. The rules that govern the balance the 
paracrine (Wnt/Ccdc80) and endocrine (ACTH/AngII) signals in this model are predicted to 
involve organotypic temporal and spatial cues. Coupled with the known role of βcat in the 
regulation of pro-zG genes, these data collectively suggest that Wnt signaling facilitates the 
unidirectional centripetal differentiation of adrenocortical progenitor cells. Specifically, the 
model predicts that Wnt-mediated inhibition of zF-associated steroidogenesis, maintenance of 
the progenitor cell pool and priming of zG cell fate, serves to assure that adrenocortical 
progenitor cells differentiate into zG cells before becoming zF cells as supported by recent work. 
See discussion for details. 
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TABLES 
Table 2.1: Primer sets for qRT-PCR 
Gene Forward Primer (5'-3') Reverse Primer (5'-3') 
Rplp0 GAAACTGCTGCCTCACATCCG GCTGGCACAGTGACCTCACACG 
Axin2 GCAGGAGCCTCACCCTTC TGCCAGTTTCTTTGGCTCTT 
Cyp11b1 GCCATCCAGGCTAACTCAAT CATTACCAAGGGGGTTGATG 
Star AAGGCTGGAAGAAGGAAAGC CCACATCTGGCACCATCTTA 
Cyp11a1 AAGTATGGCCCCATTTACAGG TGGGGTCCACGATGTAAACT 
Mc2r GTAAGTCAACGGCAAACACC GTGTCATTGGTGTGTTCATACG 
Sf1 CGCTGTCCCTTCTGCGGCTT AGCACGCACAGCTTCCAGGC 
Ccdc80 AGGCATGCAATTTTGGTCTGC ACATCTTCCCGCTCAACGAT 
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Table 2.2: Primer sets for ChIP-qPCR 
Gene Forward Primer (5'-3') Reverse Primer (5'-3') 
Star AGAGGGTCAAGGATGGAATGATT CAGTCTGCTCCCTCCCACC 
Cyp11a1 GGGAGGTCACCGCTCCATCAGC GCCAGCATACTGTCCCCACGACT 
Mc2r AACCAACCAGACATCCCCTGCC CAAGGACCTCTCCTCCCACAAAGC 
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Table 2.3: Primers for site directed mutagenesis of Ccdc80-luciferase construct 
Gene Primer (5'-3') 
Tcf site 1 Forward GGCTCTCATACTGCGAGAAGCCGCTACTTTACCAGCTGAGG 
Tcf site 1 Reverse CCTCAGCTGGTAAAGTAGCGGCTTCTCGCAGTATGAGAGCC 
Tcf site 2 Forward CCATGGGCTTTTCCAACCCAGAACTCCGCTCATAAAGCAGGCAG 
Tcf site 2 Reverse CTGCCTGCTTTATGAGCGGAGTTCTGGGTTGGAAAAGCCCATGG 
Tcf site 3 Forward CGCTCGGAAACCGCTGGACTCGGCCAGACTGCAGG 
Tcf site 3 Reverse CCTGCAGTCTGGCCGAGTCCAGCGGTTTCCGAGCG 
Tcf site 4 Forward CCTCATGCCTGCCGCCTGTAAATCCGCTCTGGATTTCCTGC 
Tcf site 4 Reverse GCAGGAAATCCAGAGCGGATTTACAGGCGGCAGGCATGAGG 
The underlined letters represent the mutations introduced to abrogate transcription factor 
binding. 
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CHAPTER III: SUMMARY AND FUTURE DIRECTIONS 
 
Previous studies established Wnt signaling as integral for maintenance of adrenal 
homeostasis. The data presented in this thesis provides mechanistic insight into how βcat 
contributes to this process and provides a deeper characterization of the Wnt-responsive 
adrenocortical progenitor cell population.  
 
In chapter two, phenotypic characterization of Wnt-responsive adrenocortical cells 
revealed a previously unappreciated heterogeneity of this population. Given that Wnt signaling is 
critical for proper adrenal development and homeostasis, we hypothesized that Wnt-responsive 
cells constituted a transit-amplifying progenitor cell pool [1]. Therefore, it was predicted that 
Wnt-responsive cells would have a shared identity with Shh-producing cells that serve as 
undifferentiated progenitors to steroidogenic adrenocortical cells [2]. While a portion of the Wnt-
responsive population is indeed Shh-expressing, a subset of the Wnt-responsive cells 
unexpectedly colocalize with differentiated cells of the zG. One caveat to this study is that our 
observations are based on transgenic reporter mice, which, depending on the half-life of the 
reporter protein could have expression artifacts or mark cells that have recently but no longer are 
responding to Wnt ligands. However, while our studies were in progress, data emerged 
supporting a role for Wnt signaling in zG biology [3], and thus reinforced our observations made 
with Wnt reporter mice.  
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Given that Wnt signaling can be mitogenic and promotes tumorigenesis in many tissues 
including the adrenal cortex [4], it is additionally unexpected that Wnt-responsive cells only 
infrequently colocalize with proliferating cells. Even more surprising is the observation that Shh-
producing progenitor cells proliferate even less than Wnt-responsive cells. These results raise 
many important questions for future study. If Shh-expressing progenitors are not ‘transit-
amplifying’, is there an undetermined population of transit-amplifying progenitors? Also, what 
are the major mitogenic stimuli of adrenocortical cells under normal homeostatic conditions, if 
not Wnt ligands? It seems reasonable that IGF and/or FGF signaling could be responsible for 
maintaining proliferation of adult adrenocortical cells. IGF2 is the most highly expressed gene in 
adrenocortical carcinomas [5], and IGFs are potent adrenal mitogens in vitro and in vivo [6-9]. 
Igf1r is enriched in the subcapsular cortex [10], positioning the IGF-receiving cells in proximity 
to where the bulk of proliferation occurs. As with IGFs, FGF2 stimulates proliferation in primary 
cultures and adrenocortical cell lines [11, 12]. FGF ligands and receptors are situated in the 
capsular and subcapsular region of the adrenal gland [13]. Mice deficient for either FGFR2 
isoforms or specifically isoform IIIb exhibit hypoplastic adrenals with disorganized capsules [13, 
14]. The embryonic lethality of these mice precludes investigation into the role of FGF signaling 
in postnatal adrenal homeostasis and growth. Conditional ablation of FGFR2 IIIb and further 
characterization of the FGF-responsive adrenal cells will be an important area for future 
research.   
 
It remains plausible that Shh+ ‘progenitor’ cells are slowly cycling and/or relatively 
quiescent and more ‘stem’-like. Lineage tracing of Shh-expressing cells utilizing Shh-CreERT2 
mice crossed with R26RmT/mG reporter animals revealed continuous patches of clonal GFP+ cells 
extending from the outer cortex to the cortical-medullary boundary [2]. These data suggest that 
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either Shh-expressing cells divide, or Shh-expressing cells proliferate after they extinguish the 
genetic program that includes Shh expression. While the vast majority of adrenocortical cells are 
undergoing continuous centripetal displacement, studies have uncovered a subpopulation of 
long-term retained cells within the capsular/subcapsular niche. Under normal physiological 
conditions, a newly divided, BrdU-labeled cell in the peripheral region transits the length of the 
cortex in 12-14 weeks [15]. 5-6 months following 2 weeks of BrdU infusion in vivo, a small 
population of label-retaining cells remained in the subcapsular region as well as the capsule [16]. 
Data emerging from the Laufer laboratory suggests that Shh+ cells are indeed a long-term 
retained population in the adrenal cortex. In lineage tracing experiments, Shh+ cells labeled 
shortly after birth persist in the outer cortex up to a year post-labeling (Dr. Edward Laufer, oral 
communication, 2012 Conference of the Adrenal Cortex). It will be of great interest to assess if 
the slowly cycling, long-term retained cells observed by Chang et al. are Shh-expressing cells. If 
true, these data would suggest that Shh+ cells are the adult stem cells of the adrenal cortex. A 
hierarchy of which adrenal cells are the ‘stem’ or ‘progenitor’ has not been clearly delineated. It 
is established that, in addition to Shh+ cells, several capsular populations (Gli1+, Wt1+) can give 
rise to adult adrenocortical cells [2, 17, 18]. However, the relative frequency with which these 
different cell types contribute to the adrenal cortex under normal homeostasis vs. regeneration 
following injury is unknown. Lineage tracing experiments from Gli1+, Wt1+ or Shh+ cells under 
regeneration paradigms, such as enucleation or dexamethasone-induced adrenal atrophy will help 
address this issue. Additionally, it will be of interest to investigate the gene expression profiles of 
the ‘stem’ cells taking a similar approach as in chapter two. GFP+ cells from Shhgfpcre or 
Gli1:GFP adrenals could isolated via FACS and subjected to gene expression analysis via 
Affymetrix microarrays or RNA-Sequencing. 
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It will also be essential to determine whether long-term retained cells in the cortex are 
Wnt-responsive and if Wnt signaling is in part responsible for their maintenance. βcat activates 
transcription of Dax1 and Dax1 deficient adrenals partially phenocopy adrenal failure observed 
in βcat knockout adrenals [1, 19, 20]. These data together suggest that βcat-mediated Dax1 
expression maintains the quiescent and/or undifferentiated state of Shh+ cells, but this has not 
been formally demonstrated. It will be important to re-examine the phenotypes of βcat and Dax1 
knockout animals crossed with Shh and Gli1 transgenic reporter animals. Are there less Shh+ 
cells and/or long-term retained cells without βcat or Dax1? Long-term BrdU pulse-chase studies 
utilizing ShhLacZ;Sf1/Crelow:Ctnnb1tm2kem or ShhLacZ; Dax-/Y will address this question. If the Shh+ 
population does not decrease in these animals, then this would indicate βcat and Dax1 adrenal 
knockout phenotypes could be due to non-cell-autonomous signaling defects on the capsular 
stem/progenitor cell niche. Lineage tracing of Shh+ and Gli1+ cells in the context of βcat or 
Dax1 deficiency would provide insight into this hypothesis. Additionally, it is unclear whether 
Wnt signaling somehow contributes to the genetic program that enacts Shh expression. While 
unpublished data from our laboratory suggest that the Shh pathway positively influences Wnt 
pathway activation, no data exists suggesting a reciprocal relationship in the adrenal gland (Finco 
and Hammer, unpublished observations). We observe that Shh-producing cells are Wnt-
responsive cells, but it is unclear if Wnt pathway activation is critical for inducing Shh 
expression. Therefore, it will be important to identify Wnt target genes in the Shh+ population. 
βcat ChIP-Seq performed on GFP+ cells isolated from Shhgfpcre adrenals would help resolve this 
question. 
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The characterization of Wnt-responsive cells in chapter two demonstrates that the 
majority of proliferating adrenocortical cells are not Wnt-responsive cells. It is plausible that 
Wnt signaling contributes to proliferation in a non-cell-autonomous fashion. Gene expression 
profiling presented herein used strict criteria to prioritize genes for further study; only genes that 
were enriched in the Wnt-responsive population in vivo and stimulated by βcat activity in vitro 
were considered for further analysis. Genes intersecting these data sets did not include any 
growth factors or cell-cycled related genes. It is possible that mitogenic paracrine factors are 
indeed under the control of Wnt signaling in vivo, but were not stimulated by induction of βcat 
activity in the fasciculata-like ATCL7 cells used for our in vitro studies. Future investigation 
could analyze only the genes enriched in the Wnt-responsive population alone. Our phenotypic 
analysis revealed that the Wnt-responsive population is heterogeneous and contains most, if not 
all of the differentiated cells of the zG. It is likely that subset of genes enriched in the Wnt-
responsive population may simply be zG genes that are not directly regulated by Wnt/βcat 
signaling. Accordingly, it may be fruitful to compare the genes enriched in our in vivo dataset 
with other adrenal gene expression data sets characterized by high Wnt signaling. For example, 
one could overlay genes from the Wnt-responsive population to those upregulated in the adrenals 
of APC knockout mice versus wildtype mice. Another comparison could include genes 
downregulated in βcat deficient adrenals versus wildtype. These experiments would keep the 
gene expression analysis within the same species and would consider both Wnt pathway gain- 
and loss-of-function in vivo. Target genes emerging from these studies are predicted to shed light 
on additional pro-growth genes regulated by Wnt signaling, and could additionally provide 
insight into how Wnt signaling promotes tumorigenesis in the adrenal cortex.  
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Data presented in this thesis demonstrates that one contribution of Wnt signaling to 
adrenocortical homeostasis is the inhibition of zF cell fate by the suppression of zF cell 
steroidogenesis. Combined with recent data reflecting a role for Wnt signaling in zG biology [3, 
21], our results suggest that Wnt signaling ensures unidirectional differentiation of adrenal 
progenitors into cells of the zG and not the zF, therefore aiding in the establishment of 
adrenocortical zonation. To test this notion further, it would be advantageous to investigate the 
distribution of differentiated cells in each steroid-producing layer in βcat knockout adrenals. It is 
predicted that, prior to progenitor cell loss and ultimate adrenal failure, βcat deficient adrenals 
may have less Cyp11b2-expressing zG cells and a higher proportion of Cyp11b1-expressing zF 
cells.  
 
Our studies indicate that Wnt signaling inhibits zF steroidogenesis through suppression of 
Mc2r gene expression and subsequent downstream signaling from Mc2r, as well as through 
direct effects on Sf1-meditated transcription of other steroidogenic genes. Very recently, 
researchers determined that canonical Wnt signaling augments zG steroidogenesis through 
indirect regulation of aldosterone production [3]. While it appears contradictory that Wnt 
signaling could both positively and negatively influence steroidogenesis within the same cell, 
several explanations exist to address this contradiction. Steroidogenesis in the zG is under 
control of the RAAS, intracellularly involving PLC, PKC and calcium signaling, whereas the 
HPA axis and cAMP/PKA signaling regulates the steroidogenesis in zF cells. Our laboratory and 
others have only considered the effects of canonical Wnt/βcat pathway on steroidogenesis and 
have not investigated noncanonical Wnt signaling. It is interesting to note that calcium signaling 
is a branch of noncanonical Wnt pathway [22]. It has been demonstrated that the same Wnt can 
promote both canonical and noncanonical Wnt signaling dependent on cellular context [23], and 
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that canonical/noncanonical signaling within a single cell is not mutually exclusive [24]. It will 
be important to determine which Wnt ligands are expressed in the adrenal, in addition to which 
branch of Wnt signaling they stimulate. Wnt4 is expressed in subcapsular cells and has been 
shown to engage both the canonical and noncanonical pathway in different tissues [25, 26]. As 
Wnt4 is a target of the canonical pathway itself [27, 28], it is unclear whether Wnt4 promotes 
feed-forward activation of the canonical pathway, and/or if it can elicit calcium signaling to 
promote zG fate and steroidogenesis or both. Mice globally deficient for Wnt4 exhibit less 
Cyp11b2 expression at birth suggesting that Wnt4 does impact zG steroidogenesis [29]. It will 
important to determine if Wnt4 is eliciting these effects through a canonical or non-canonical 
mechanism with in vitro studies utilizing adrenal cell lines that do not contain gain-of-function 
mutations in the Wnt pathway yet have the capacity to express Cyp11b2 and synthesize 
aldosterone. Wnt4 global knockout mice die perinatally due to kidney malformation [30]. 
Accordingly, it would be advantageous to employ a conditional allele of Wnt4 in the 
steroidogenic cell lineage to investigate the potential role of Wnt4 on adrenal zonation, 
homeostasis and aldosterone production during adulthood.  
 
The molecular data in chapter two indicates that βcat inhibits zF cell steroidogenesis by 
suppressing Sf1-mediated transactivation of steroidogenic genes. In the ATCL7 zF-like cell line, 
induction of βcat activity reduced Sf1 expression at the mRNA and protein level. It is unclear 
whether βcat affects Sf1 protein stability. Pulse-chase experiments utilizing 35S-methionine 
would clarify this issue. Our data demonstrates that when Sf1 protein levels are equivalent, βcat 
suppresses Sf1 activation of steroidogenic promoters in reporter assays. These data are likely a 
reflection of reduced Sf1 occupancy or reduction in recruitment of coactivators, or both. These 
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data are interesting in light of studies demonstrating that βcat and Sf1 synergistically activate 
transcription of several genes, including Dax1 and Inhα, which are critical for adrenal progenitor 
biology. It is possible that βcat titrates Sf1 away from steroidogenic promoters and recruits Sf1 
to the promoters of Dax1 and Inhα for expression of genes critical for maintenance of 
progenitors cells. It is also likely that the suppression of Sf1-mediated expression of 
steroidogenic promoters could be due to effects on co-regulator recruitment. Our data indicates 
that reduced Mc2r expression is correlated with a reduction in PKA signaling, resulting in less 
phosphorylation of Creb, a known coactivator of Sf1 for steroidogenic gene expression [31]. It 
would be worthwhile to assess if loss of occupancy of pCreb or other factors is correlated with 
and contributes to loss of Sf1 on steroidogenic promoters.   
 
 Gene expression profiling in chapter two unveiled Ccdc80 as a novel Wnt-responsive 
gene encoding a secreted factor that participates in the suppression of zF steroidogenesis. It is 
unclear how Ccdc80 blunts basal and ACTH-induced steroidogenesis, as Mc2r-initiated 
cAMP/PKA signaling and Sf1 levels are unaffected in the presence of Ccdc80 conditioned 
media. The function of Ccdc80, as well as its potential signaling mechanism, is poorly 
understood. In the chick eye lens, reports suggest that Ccdc80 binds heparan sulfate 
proteoglycans and modulates FGF signaling [32]. Aside from potential mitogenic effects of 
FGFs (as discussed above), it is unknown if FGF signaling influences adrenal steroidogenesis. 
FGF stimulates the Janus kinase/Signal transducer and activator of transcription (JAK/STAT) 
pathway in a context-dependent manner [33]. A recent report implicated JAK2 in prolactin-
mediated adrenocortical steroidogenesis [34]. Therefore, it is intriguing to speculate that the 
inhibitory effects of Ccdc80 on corticosterone production could be due to modulation of an intra-
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adrenal FGF-JAK/STAT signaling axis. To test this hypothesis, it will be essential to determine 
whether adrenal-expressed FGFs induce JAK/STAT activation and whether manipulation of 
these factors impact steroidogenesis. One intriguing aspect of Ccdc80 is its subcellular 
localization. While predominantly secreted in most cell lines examined [35-38], Ccdc80 is 
present in the cytoplasm in some reports [38, 39] and in the nucleus of thyroid cells [40]. While 
its intracellular actions are not well characterized, O’Leary et al. demonstrated that Ccdc80 is a 
binding partner of JAK2. While Ccdc80-binding does not increase the level of phosphorylation 
of JAK2, this binding event somehow facilitates JAK2-mediated phosphorylation of STAT 
proteins. The experiments performed in chapter two utilizing Ccdc80 conditioned media only 
investigated the extracellular effects of Ccdc80 on steroidogenesis. It will be critical to determine 
whether Ccdc80 is retained intracellularly and if Ccdc80 influences JAK/STAT signaling 
through extracellular or intracellular mechanisms. 
 
It is likely that the dual role for Wnt signaling in progenitor maintenance and zG 
differentiation is dictated by the integration of Wnts with endocrine signals and paracrine factors 
such as Ccdc80. Data presented in this thesis demonstrates that Ccdc80 inhibits zF-associated 
steroidogenesis, however it remains unknown whether Ccdc80 impacts zG biology. If Ccdc80 
stimulates basal or AII-stimulated aldosterone production, this would suggest that Ccdc80 
contributes to the unidirectional differentiation of adrenal progenitors and thus adrenal zonation. 
However, it is equally possible that Ccdc80 suppresses aldosterone synthesis. This would 
implicate Ccdc80 in maintaining the undifferentiated state of adrenocortical progenitors, akin to 
the actions of Dax1. An evaluation is needed on the potential role for Ccdc80 on aldosterone 
synthesis in vitro and adrenal zonation in vivo. It is of great interest to determine whether Ccdc80 
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deficient adrenals will phenocopy βcat and Dax1 knockout adrenals and implicate Ccdc80 in 
adrenocortical homeostasis. 
 
In summary, the data presented in this thesis demonstrate that the heterogeneous Wnt-
responsive population contains progenitors and differentiated cells of the zG, but not the zF. Wnt 
signaling likely promotes the unidirectional differentiation of adrenal progenitors into zG cells 
by inhibiting zF cell fate. This is achieved in part through the novel inhibitory actions of βcat on 
Sf1-mediated zF-associated steroidogenesis. βcat also induces expression of Ccdc80, a paracrine 
factor, with an unknown mode of signal transduction, which additionally participates in the 
inhibition of zF steroidogenesis through yet determined mechanisms. Collectively, these data 
highlight the complexity with which Wnt signaling contributes to adrenocortical homeostasis. 
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